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Introduction 
I n  1 9 9 0 , there were approximately 5 0 5 , 0 0 0  cancer rel ated 
deaths in the United S tates ( Boring et al . ,  1 9 9 4 ) . In t he 
s ame year , there were 2 0 , 5 0 0  new cases of primary brain tumor 
and 2 0 , 7 0 0  new c a s e s  o f  me t a s t at ic b r a i n  tumor . T h e  
e s t imated numbe r o f  de aths i n  t h e  U n ited S t a t e s  due t o  
pr imary brain tumors i s  approximately 1 1 , 0 0 0  ( P rados and 
wilson 1 9 9 3 ) . The estimated number o f  1 9 9 2 c ancer deaths due 
to metastases from : lung , breast , colon and rectum , and s kin 
wa s 4 1 , 6 0 0  ( Wright et a l . ,  1 9 9 3 ) . G l ioma s , tumo r s  o f  
trans f ormed gl ial c e l l s , c omprise 5 0 %  o f  a l l  pr imary brain 
tumors ( Radhakrishnan et al . ,  1 9 9 4 ) . The mos t  common forms of 
g l ioma are astrocytoma , oligodendrogl ioma , and g l iobl as t oma 
multiforme ( Laws and Thapar 1 9 9 3 ) . 
Gl ioblas toma mu ltiforme ( GBM ) is at the extreme scale o f  
ma l ignant as trocyt ic tumors . There is a s l ight proc l ivity 
for the disease to occur in males ( Sc h i f f e r  1 9 9 3 ) . The mean 
age for a patient who i s  di agno s e d  with GBM i s  54 years 
( p r ado s and wi l s o n  1 9 9 3 ) . I n  add i t ion t o  e ndot he l ia l  
prol i feration , hyperc e l l u l ar ity , pleomorphis m ,  and atypic a l  
mitot ic f igure s , GBM i s  c haracte r i z e d  b y  l arge are a s  o f  
nec ros is whic h dist ingu i s he s  i t  f rom anap l a s t ic a s trocytoma . 
The tumor i s  u s u a l ly loc ated in t he white matte r  o f  the 
cerebra l hemis phere s . They occur in many d i f f e re nt regions 
of the cerebral hemi s phere s inc luding the : f rontolate r a l , 
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temporol ateral , parietodor s a l , and occ ipitodor s al re g io n s . 
GBM c an also occur in the corpu s callosum ,  bas al gangl ia , and 
the thalamu s . GBM is al so characterized by their inf iltrative 
nature , as they are known to act ive ly invade the cortex and 
white matter ( Schif fer 1 9 93 ) . GBM has been c l as s if ied by t he 
World Health Organiz ation ( WHO ) as a Grade IV tumor ( Kl eihue s 
et a l . ,  1 9 9 3 ) . Over a ten year period , S alcman et al e ( 1 9 9 4 ) 
treated 2 8 9 pat ients ( 7 3 . 7 % Grade IV and 2 6 . 3 % Grade I I I ) who 
had g l iomas . Fifty-three patients rece ived only s urgery and 
radiation therapy , and a n  additional 7 4  patients were a l s o  
given s ome form o f  nitrosourea chemotherapy . I n  1 1 3  c a se s , 
the patient s were adminis tered some form of experimental drug 
therapy , surgery , and radiat ion therapy in addition to or in 
p l a c e  of nitrosourea . Thirty - s even p a t ie n t s  we re g ive n 
inte r s t it ial imp l ants in addit ion to s urge ry , rad i a t i o n  
t he r a py , a n d  c hemotherapy . Al s o , 5 8 %  o f  the p a t i e n t s 
u nde rwe nt repeated s u rgery at s ome p o i n t  d u r i n g  t he i r 
c l inical course . O f  the pat ient s who underwent s u rgery and 
radiation therapy, those that were less than 40 years of age 
had a med ian survival o f  2 0  mont hs , and pat ie nt s  who were 
o l de r  t han 4 0  ye ars ha d a median s u rviva l o f  7 mont h s . 
P a t i e n t s  under t he age o f  40 who we re g iven n it ro s oure a  
c hemotherapy in addit ion to s urgery and radiation therapy had 
a mean survival of 2 6  months , and the patients who were o lder 
than 4 0  had a median survival of  1 1  months . I n  t he group o f  
patients who underwent exper imental drug t he rapy , patient s 
unde r the age o f  4 0  had a median s urvival o f  2 4  month s ,  and 
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those that we re over 4 0  years had a median s u rviva l o f  1 4  
months . Of the 3 7  pat ient s who a l s o  u nderwent inte r s t it i a l  
imp l ant s , patient s under the age o f  4 0  had a median s u rvival 
of 2 9  months , and patient s over the age o f  4 0  had a median 
s u rviva l of 1 4  month s . I n  this s tudy , patient s with Grade 
I I I  tumors who were younger than 4 0  years ( n=2 7 ) had a median 
survival of 3 7  months ,  and those who were older than 4 0  years 
( n=4 9 ) had a median s urviva l o f  1 5  month s . Patient s with 
Grade IV tumors who we re younger than 4 0  years ( n=6 2 ) had a 
med ian survival o f  2 4  months , and those who were older t han 
4 0  years ( n= 1 5 1 ) had a med ian survival o f  12  months . Tho s e  
patient s who u nderwent repeated s urgery had an addit ion a l  
survival time of 9 months . 
Anaplastic astrocytoma ( AA )  is a mal ignant brain tumor 
that has been c l as s i f ied as a Grade I I I  tumor by the WHO 
( K le ihues et a l . ,  1 9 9 3 ) . The med ian age for individu a l s 
d iagnos ed with anaplastic astrocytoma is 4 5  years ( Prados and 
wil s on 1 9 9 3 ) . As with GBM , there is a s l ight tendency for AA 
to occur more often in males (Zulch 1 9 8 6 ) .  Compared to l ower 
grade astrocytomas ( Grade I and I I ) ,  AA is more inf iltrat ing , 
and t hey s how a greater prope n s ity to invade the c ortex 
( Sc h i f f e r  1 9 9 3 ) . AA is c h a r a c t e r i z ed by mo d e r a t e  
hyp erc e l l u l ar ity and mode rate p l e omorph i s m . T h ey a l s o  
undergo vas c u l ar prol iferation whic h i s  inve r s e ly rel ated to 
the length of survival . AA lacks nec ros is ( Jellinger 1 9 8 7 ) . 
Fo r pat ient s with GBM o r  AA , s u r g e ry i s  u s u a l l y  
per f ormed i n  order t o  remove a s  muc h  o f  t he tumor a s  s a f e ly 
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pos s ible , to alleviate symptoms , to make a diagnos is , and to 
pre s erve l i fe . However ,  due to the i n f i l trat ive nature o f  
t he s e  tumor s , s urgery i s  not ab l e  to remove 1 0 0 %  o f  t h e  
tumor . I n  pat ients with GBM and AA , surgical resect ion i s  
u s u a l ly f o l l owed b y  radiation the rapy ( Prados and Wi l s o n  
1 9 9 3 ) . Di f f erent radiation t he rapy reg ime n s  have b e e n  
s tudied . Some inves t igator s favor whole brain radiotherapy 
wh ile others pre fer part ial brain irradiation . Conventional 
rad iotherapy has bee n  de f ined as a tumor dos e  o f  5 0 - 6 0  Gray 
( Gy )  given in s ingle fract ions o f  1 . 8 - 2 . 0  Gy per day , S day s  
p e r  week ( S he l ine 1 9 9 0 ) . A Gray is t he unit by wh ic h the 
quant ity of radiat ion is expre s s ed . One Gray is equal to 1 
Joule / kilogram which is also equal to 1 0 0  rad . 
Dos imet ry is t he dete rminat ion o f  how much dos e  s hould 
be depos ited within dif ferent biological tis sues . It i s  both 
a c ru c i a l  and a c omp l e x  a s pect o f  radiotherapy . Many 
variables are cons idered when determining dos age . The target 
vo lume is an import factor u s ed to determine the radiation 
dos age . Al so , there are many dif ferent s ources o f  radiat ion 
in u s e . S ome o f  t he sources produce rad iation by decay ; 
there fore , the hal f - l ife o f  the s ource whether it is iodine-
1 2 5  ( 6 0 . 2 days ) or c obalt - 6 0  ( 5 . 3  years ) is a n  import ant 
element o f  dos imetry . 
computed tomography ( CT )  and magnet ic re s onance imaging 
( MRI ) produce anatomic images in mu ltiple planes us ing x- rays 
and high f requency radio wave s re s pect ive ly ( Khan 1 9 9 4 ) . 
C omputed t omography re l ie s  upon t he attenuat ion o f  x - rays 
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wit hin tis s ue . Attenuation is the removal o f  x- ray photons 
f rom t he beam . 
pro pe r t i e s  wi t h i n  
T h e r e  are ma ny d i f f e re n t  at t e n u at i o n  
t i s s ue . Re g i o n s  o f  b r a i n  edema a n d  
areas o f  l ow at tenuation and hypode n s i t y . ne c r o s i s  are 
C ompa red to edema and ne c ro s is , g l ioma s are r e g i o n s  o f  
g r e a t e r  atte nuat ion . By t he ir very n a t u r e , t hey a r e  
hype rc e l l u l a r ; t h e re f o r e , t h e y  appe a r  a s  r e g i o n s  o f  
hyperdens ity on CT ( Lee et al . ,  1 9 9 2 ) . 
Magnetic res onance imaging re l ie s  upon the abundance o f  
protons within the body . The protons are pres ent in the form 
of water .  At equ i l ibrium , there is a net magnetiz at ion o f  
the proton nuc lei i n  a parallel direction . Exc itation in t he 
form o f  a radio wave provide s torque to t he longitud i n a l  
ma g ne t i z at io n  ve c t o r . T h e r e  i s  a d e c r e a s e  i n  t h e  
longitudinal magnetiz at ion and a n  increase i n  the trans ve r s e  
magnet ization . Once the radio wave is turned of f ,  there is a 
l o s s o f  the exc it at ion ene rgy to t h e  ove r a l l  t he rma l 
e nvironment , te rmed s p in- l at t ice inte ract ion s . The t ime 
c o u r s e  a s s o c i ated wit h t he rec ove ry o f  l on g i t u d i n a l  
magne t i z at ion i s  T l . Al so , there i s  a n  exc hange o f  energy 
betwe e n  ne ighboring nuc lei te rmed s p i n - s p in interac t ion s . 
The t ime course for t he los s o f  transverse magnet i z at ion is  
T2 . I n  tumors and areas of edema , water is wide ly disper s ed ; 
t he re f ore , the ab il ity o f  the proton s  to impart energy t o  
their environment is poor . This is man i f e s t  as a s l ow dec ay 
of the exc ited st ate and a low s ignal . Subs equently , tumors 
and edematou s tis s ue appear dark on T l  we ighted MRI . S o l id 
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t is sues are able to give up energy more rapidly bec au s e  t he re 
is  a more direct coupl ing between molecule s .  Th is re s u l t s  
in : a rap id dec ay o f  the exc ited s tate , a h igh s ignal , and 
t h e  appearance o f  s o l id t i s s ue a s  l ig hte r are a s  on T 1  
we ighted MRI . On T2 we ighted MRI , tumo r s  and edematou s 
t i s s ue appear as l i ghte r re gions wh ile s o l id t i s s ue s  appear 
darker ( Lee et al . ,  1 9 9 2 ) . 
C o n t ra s t  e n h a n c i n g  s u b s t a nc e s  s u c h  a s  iod i ne a n d  
gadol inium are used i n  C T  and MRI res pect ively . The pres e nce 
o f  contrast enhancement indicates a disturbance in the b l ood 
brain barrier . Normal brain vascul ature has an intact blood 
brain barrier composed of t ight junctions between endothel ia l  
cel l s , a surrounding bas ement membrane , and a n  inves tment o f  
astrocytic foot proce s s e s . Regions of the brain where t he re 
is  GBM or AA us ual ly tend to contras t enhance , corre s ponding 
to endothel ial proliferat ion and neovascularization ( Woodru f f  
1 9 9 3 ) . 
Determining the mic ro s c op ic margins o f  the target i s  
impo s s i b l e  eve n wit h t h e  be s t  C T  and MRI ava i l ab l e ; 
there fore , the radiation therapy target mus t  include a margin 
beyond the target de f ined by CT or MRI . At the univers ity o f  
California San Francisco , the target volume inc lude s at least 
3 cm beyond that indicated by CT and 2 cm beyond what is 
dete rmined by MRI . There are many prognos t ic factors o f  
s u c ce s s rel ated t o  the radiat ion ther apy o f  GBM and AA 
inc luding : tumor necros is , age , Karno f s ky performance s tatus , 
ex tent o f  re s e c t ion , and decrea s e  in t umo r s i z e  a f te r  
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radiotherapy ( Shel ine 1 9 9 0 ) . 
Metastas i s  is  de f ined a s  a migrat ion in t he b l ood and 
lymphatic sys tem o f  tumor ce l l s  t hat g ives rise t o  tumo r s  
e l s ewhere in the body ( Mahadevan and Hart 1 9 9 0 ) . The 
inc idence o f  cerebral metastases varie s f rom 2 . 8  to 1 1 . 1  per 
1 0 0 , 0 0 0  ( Schif fer 1 9 9 3 ) . Autopsy s tudie s have s hown that up 
to 5 0 %  of  peop le dying of  cancer wil l  pos s e s s intracerebral 
metastases , of  these 4 0 %  are s ingle les ions ( P ickren et a l . ,  
1 9 8 3 ) . Tumors of  the s kin , breas t , l u ng , kidney , and the 
d i g e s t ive t r a c t  are r e s p o n s i b l e  for 9 5 %  of c e r e b r a l  
me t a s t a s e s . Met a s t a s e s  f rom l u n g  c a n c e r  are t h e  mo s t  
preval e n t , repre s e nt ing mo re t h a n  5 0 %  o f  a l l  c e r e br a l  
met astase s .  There i s  a tendency for cerebral metastas e s  t o  
oc cur i n  male s ; t he inc idence is  9 . 7  pe r 1 0 0 , 0 0 0  f or mal e s  
and 7 . 1  per 1 0 0 , 0 0 0  f o r  fema les . Approx imate ly 8 0 % - 8 6 %  o f  
cerebral metastases are local ized supratentorial ly with in the 
frontal , temporal ,  and parietal regions ( Sc hif fer 1 9 9 3 ) . 
Metastas e s  from me lanoma and renal c e l l  carcinoma are 
c o n s i d e r e d  to b e  r a d i o r e s i s t a n t , wh i l e  t ho s e  f r o m  
adenoc arc inoma and s quamou s c e l l  carcinoma are c l as s i f ied a s  
radiosens it ive ( Loe f f ler e t  al . ,  1 9 9 1 ) .  The median s u rvival 
of patients with a cerebral metastas is is u s ual ly only a f ew 
mont h s  i f  l e f t  u ntreated . Du ring this pe r iod there i s  a 
progre s s ive neuro logic a l  dete r iorat ion ( E ngenhart e t  a l . ,  
1 9 9 3 ) . Maor et ale ( 1 9 8 8 ) treated 3 9  patient s who had renal 
c e l l c arc in oma met a s t at ic to the brain wit h who l e  b r a i n  
irradiation ( 3 0 Gy i n  t e n  fractions ) .  Of the 3 3  patients who 
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we r e  f o l l owe d - u p , 2 3  p a t i e n t s d i d  n o t  r e s p o n d  o r  
deteriorated . Ten patients responded to the radiotherapy and 
had a median s u rviva l of 1 7  weeks . The ent ire t re atme n t  
group had a median survival of 8 weeks . Vec ht et al e ( 1 9 9 3 ) 
treated 3 1  pat ient s who had a s ingle metas t a s i s  to the brain 
wit h whole brain irradiation ( 2  f ractions per day o f  2 Gy 
each for a total o f  40 Gy ) .  The origin o f  t he met a s t a s e s  
were : l ung ( n=1 6 ) , breast ( n=6 ) , renal c e l l  ( n=I ) , melanoma 
( n=4 ) , and others ( n=4 ) . The patients had a median survival 
of 6 months . 
Patche l l  et al e ( 1 9 9 0 ) conducted a randomized trial o f  
s u r ge ry and rad iothe rapy in t h e  t r e a tme n t  o f  s i n g l e  
metastases to the brain . One group underwent a treatment o f  
s urgical removal o f  the brain tumor fol lowed by who le-brain 
radiat ion therapy ( s urgic a l  group ) .  The s ec ond group o f  
patients underwent need le biop sy and whole -brain rad iat ion 
therapy ( radiation group ) .  The re s u l t s  indic ated that t he 
recurre nce at the s ite of the original met astas is was l e s s  
f requent in the surgical group than in the radiation group ( 5  
o f  2 5  [2 0 %] ver s u s  1 2  of 2 3  [5 2 %] .  The overal l length o f  
s u rviva l wa s s ign i f ic antly longer i n  t he s u r g ic a l  group 
( median 4 0  weeks ve r s u s  1 5  weeks in the rad iat ion group ; 
P< O . OI ) . Al s o , t he pat ient s treated wit h s urgery rema ined 
function a l l y  independent longer ( median , 3 8  wee ks versu s  8 
weeks in the radiation group ; P<0 . 0 0 5 ) . 
I n  orde r to meas ure a patient ' s  qual ity o f  l i f e , mos t  
c l i n ic i a n s  wi l l  make a n  eva l u at ion u s i n g  t he Karno f s ky 
Per f ormance Sc ore ( KPS ) ( Karno f s ky 1 9 4 5 ) . 
from 1 0 0 %  to 0 %  ( Table 1 ) . 
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The KPS range s 
X- rays were discovered by Roentgen in 1 8 9 5 . S ince t he n , 
radiotherapy has pl ayed an integral role in the treatment o f  
c ancer . Radiotherapy has become the s tandard post -operat ive 
procedure for pat ient s with ma l i gn a nt a s t rocytoma s  a n d  
met a s t a s e s . Recent ly , radios urgery ( Linear Acce lerator a n d  
Gamma Knife ) h a s  been introduced into the United State s , and 
many ho s p ital s have been u s ing this procedure to t reat a 
my riad of les ion s . This paper i s  be ing writte n to expl o re 
the role of radiosurgery in the treatment o f  mal ignant brain 
tumors . Al so , the biological and phy s ic al princ ip l e s  that 
underl ie radiosurgery wil l  be discus s ed . Furthermore , t h i s  
paper wil l review many of the radios urgic al studies that have 
been per formed in the t re atment of ma l ignant brain tumor s . 
Final ly , an experiment wil l  be proposed to s tudy the e f fects 
o f  growth factors on the total obl iterat ion t ime course o f  a 
rat model for arteriovenous mal format ions . 
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Table 1 
From: Karnofs k y  OA, Burchenal JH: The clinical evaluation of 
chemotherapeutic agents in cancer. In MacLeod CM ed. Eyaluation of 
Chemotherapeutic Agents, Columbia University Press, New York, 191-205, 
1945. 
Karnof sky Performance Score 
Percentage 
100% 
90% 
80% 
70% 
60% 
50% 
40% 
30% 
20% 
10% 
0% 
Comments 
Normal, no complaints, no evidence of 
disease. 
Able to carry on normal activity, 
minor signs or symptoms of disease. 
Normal activity with effort, some 
signs or symptoms of disease. 
Cares for self. Unable to carry on 
normal activity or to do active work. 
Requires occasional assistance, but 
is able to care for most needs. 
Requires considerable assistance and 
frequent medical care. 
Disabled, requires special care. 
Severely disabled, hospitalization lS 
indicated, although death is not 
imminent. 
Hospitalization necessary, very sick. 
Moribund. 
Dead. 
Rad i o b i o l o gy 
The goal o f  radiat ion therapy i s  t he steril i z at ion or 
l o s s of  r e p r od u c t ive i n t e g r it y  of  ma l i g n a n t  c e l l s  
( We ichselbaum 1 9 9 3 ) . The primary cel lular event that res u l t s  
f rom radiot herapy is DNA damage wh ich c an be c l as s if ied a s : 
doubl e - strand breaks , s ingle - s trand breaks , cros s - l inking o f  
DNA t o  DNA or to other molecules , or base damage . Repair may 
be undertaken in s ome tumor c e l l s  by enzymat ic sys tems s u c h  
as nuc l e a s e s  a n d  l iga s e s  ( Sc h i f f e r  1 9 9 3 ) . unrepaired o r  
mi s repa ired doub le s t rand breaks a r e  b e l ieved to be t h e  
c ritical component involved in produc ing pro l i ferat ive ce l l  
death . Proliferat ive c e l l  death wil l eventua l ly res u lt in 
nec ros is and degenerat ion o f  target t i s s u e s  o f  radiotherapy 
( Lars son 1 9 9 2 ) . 
Gamma rays and X- ray s  are c l a s s i f ied a s  l ow l i ne a r  
energy trans fer radiat ions which yie l d  re l at ive ly low dos e s  
o f  energy along t heir path ( 0 . 3 - 2 . 0  kev / micromete r ) . Whe n  
photons interact with water , they produce f ree radical s ( OH. 
and H· ) which damage DNA by extrac t ing hydrogen ions . This 
i s  termed indirect DNA damage . Under hypox ic cond it ion s , 
reducing agent s such as s u l f ahydryl compounds may repair the 
damage . Direct kil l ing o f  ce l l s  generally involves radiation 
do s e s  in exc e s s  of 1 0 0  Gy and has been termed inte rpha s e  
death ( Schif fer 1 9 9 3 ) . I nterphas e  death is c haracterized by 
the lys is and des truction of the ce ll at approximately one to 
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four hou rs after irrad iation . I nterph a s e  death doe s not 
require t he cell to pas s through mito s is . The mos t  l ike ly 
target s inc lude cel lular or nuc lear membrane s .  I t  has been 
hypothes ized that damage to mitoc hondrial membrane s c o u l d  
h ave an adve r s e  e f f e c t  o n  e n e rgy produ c t ion . Al s o , a 
breakdown of the lys o s omal membrane s wou l d  c a u s e  int e r n a l  
l y s i s  o f  the c e l l . The t arget s f o r  d i rec t d amage a r e  
primarily nondividing cel l s  s u c h  as neurons ( Kilmer 1 9 9 4 ) . 
Wit hin the c e l l  cyc le , c e l l s  in mito s i s ( M  phas e ) o r  
those i n  late G2 phase are radiosens itive . Cells which are in 
the late S phase are radiores is tant ( Hall 1 9 9 1 ) . Tumor cel l s  
by their very nature undergo a high rate o f  mitos i s . Al l 
tumor ce l l s  are thought to contain a popu l at ion of hypoxic 
cel l s  ( up to 1 5 % ) . Hypoxic c e l l s  are not pre sent in normal 
brain t is sue . They are more radiores is tant than oxygenated 
cel l s . I n  order to produce the s ame radiobiological e f fect , 
hypox ic ce l l s  mu s t  be s u b j ected to a rad iat ion dos e  thre e  
t ime s larger than t hat requ ired b y  oxygenated c e l l s . T h i s  
has been termed the oxygen enhancement ratio ( Schif fer 1 9 9 3 ) . 
When a ce l l i s  irradiated by either X-ray s  or gamma 
ray s , s ome portion of c e l l s  do not undergo lethal d amage . 
The s e  c e l l s  h ave endured s u b l e t h a l  damage wh ic h c a n  be 
repaired u s u a l ly within an hour . However as the radiat ion 
do s age is inc re a s ed , the propo rtion of c e l l s  wh i c h  a re 
lethally damaged increas e s . Theref ore , the proport ion o f  
ce l l s  wh ic h are able to undergo repair decrea s e s  ( Sc h i f f e r  
1 3  
1 9 9 3 ) . 
The reactions o f  the brain to irradiation c an be p l aced 
into three c ategories . An acute reaction may oc cur du ring 
the cours e or a few days a fter irrad iat ion . This reac t ion 
manifests its e l f  through uncharacteris t ic headac he and s igns 
of i nc rea s ed intrac r a n i a l  p re s s u re s u c h  a s  nau s e a  a n d  
vomit ing . The s ymptoms a r e  gene r a l ly reve r s ible wit h i n  
hours . The early-de l ayed reaction occurs within a few weeks 
or months a fter radiotherapy . This react ion is characteri z ed 
by lethargy and s omno lence . The e f fects are temporary i n  
nature , and they may be revers ible within a few weeks without 
tre atment . Late reac t ions gene r a l l y  man i f e s t  t hems e lve s 
with in months or years a f ter irrad iat ion . The re s u l t s  are 
u s u a l ly irrever s ible , progre s s ive , and t hey eventua l l y  l e ad 
t o  death . L at e  re a c t ions re s u l t  i n  va s c u l ar d ama g e , 
necros is , and perifocal edema (Sauer 19 8 7 ) .  
When the brain is irradiated with high doses (1 4 - 7 0  Gy ) ,  
the f ir s t  c e l l  popu l at ions to be e radic ated are tho s e  wit h  
t he h ighe s t  rate o f  mitos i s . Within norma l  brain t i s s ue , 
endothelial and ol igodendrogl ial cel l s  are the mos t  sens itive 
t o  t h e e f f e c t s  o f  i r r a d i a t i o n  (L a r s s o n  1 9 9 2 ) . 
Ol igode nd ro g l i a l  c e l l s  are i nvo lved i n  e a r l y  d e l ayed 
radiation damage . Endothelial cel l s  are identi f ied with l ate 
delayed radiation in j ury (Ros ander et al . ,  1 9 9 1 ) . 
The term radiore s i s tant de scribe s a tumor c e l l  that i s  
able to repair damage o r  produce s e l f  replacement at a r ate 
equ a l  to the s urrounding normal brain t i s sue . H ig h - g r ade 
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as trocytoma ce l l s  are cons idered t o  be very radiore s i s tant 
( S auer 1 9 8 7 ) . One o f  the ob j ec t ive s o f  rad iosurgery i s  to 
ove rc ome t he radiore s i s t a nce of  c e r t a i n  ma l ignant b r a i n  
tumors . Radiosurgery enables t h e  del ivery o f  high dos e s  o f  
radiat ion ( gamma rays o r  X- rays ) to a s te reotact ic a l l y  
demarcated target wit hout expos ing t he s u rrou nding norma l  
b r a i n  t i s sue t o  t oxic dos e s  o f  radiat ion ( Al exander and 
Loe f f ler 1 9 9 2 ) . 
In t e r s t i t ial Brachy the rapy 
Inte r s t it i a l  brachytherapy i s  a n  inva s ive procedure 
which a l l ows for the stereotactic del ivery o f  tumoric ida l  
dos e s  b y  rad ioac t ive sourc e s  which are impl anted direct l y  
into t h e  tumor . In the United S t ate s , the proc edure wa s 
f i r s t  u s ed to treat ma l ignant g l iomas at t he Univers ity o f  
C al i fornia San Franc isco i n  1 9 7 7 . Radioact ive sourc e s  t hat 
have bee n us ed inc l ude : gold - 1 9 8 , ir idium- 1 9 2 , and iod ine -
1 2 5 . Two advantages of  interstit ial brac hytherapy inc lude : a 
s harp do s age drop o f f  a s  the d is t an c e  f rom the t umor 
increases , and the favorable radiat ion biology o f  a low dos e  
rate o f  irrad iat ion (approx imate ly 0 . 4  t o  0 . 6  Gy pe r hour ) 
( McDermott et al . ,  1 9 9 1 ) . Interstit ial brac hytherapy tria l s  
have been conducted in the init ial manageme nt o f  patient s 
wit h g l iob l a s toma (LOe f f l e r  et a l . ,  1 9 9 0 b ) . Al s o , t h i s  
tre atment modal ity h a s  be e n  u s e d  to t reat pat ient s with 
recurrent malignant gl iomas (Leibel et al . ,  1 9 8 9 ) . 
Ge n e r a l l y s p e a k i n g , p r o l i f e r at i n g  c e l l s  a r e  mo s t  
s e n s it ive to radiat ion at t he G2 and M phas e s  o f  t he c e l l 
cycle . During the cont inuous low dose irradiation emitted in 
brachytherapy , ce l l s  in the res i s t ant pha s e s  o f  the c e l l 
cyc le may proceed to the sens it ive phases . This phenomenon 
o f  red i s t r ibut ion a l l ows for a more e f f e c t ive k i l l i n g  o f  
tumor cel l s . It has been hypothes i zed that the tot a l  do s e  
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per cell cycle is an important f actor in halting mitos i s . In 
vivo and in vitro s tudie s have s hown that mos t  c e l l  s y s t ems 
requ ire between 7 . 2 and 9 . 9  Gy per cyc le to inhibit mito s i s . 
S ince most brachytherapy protocols use a dose rate of  between 
0 . 4  and 0 . 6  Gy per hour , and mal ignant g l iomas have ce l l  
cyc le t ime s anywhere between 2 4  and 1 2 0  hours , the de l ivered 
do s a ge wi l l  u s u a l l y  be above the c r i t i c a l  va l u e  f o r  
inhibiting cell mitos is (McDermott e t  al . ,  1 9 9 1 ) . 
The most popu lar is otope in North America is iodine- 1 2 5 . 
The is otope is absorbed onto re s in bal l s  and s urrounded by a 
0 . 0 5 mm thick t itanium c apsule that is approximately 4 mm in 
lengt h  and 0 . 8  mm in diameter . This c o n f ormation i s  what 
make s up the so cal led " s eeds " .  There are two forms o f  t he 
125I seeds : high activity (1 0 - 5 0 mCi )  seeds which are used for 
cerebral metastas e s  and mal ignant gl iomas , and low activity 
(0 . 5  mC i ) which are u s ed for the permane nt impl antation o f  
s ku l l  base neop l a s ms . A Curie (C i )  i s  a u n it b y  wh ic h 
act ivity is me a s ured . One C u r ie i s  equal to 3 . 7  x 1 010 
dis integrations per second . The iodine - 1 2 5  isotope decays by 
electron c apture with the subs equent emis s ion o f  gamma rays , 
x - ray s , and e l ectrons . The e l ectrons and t he x- rays are 
abs orbed by the t itan ium c ap s u l e . The gamma ray s  that are 
emitted have an energy of between 27 and 35 keV (McDermott et 
al . ,  1 9 9 1 ) . 
Wha t  i s  Radio s urgery? 
I n  1 9 5 1 , L a r s  L e k s e l l  i n n ov a t e d  s t e r e o t a c t i c  
rad iotherapy o f  t he brain (Leks e l l  1 9 5 1 ) .  The tec hnique 
ut i l ized a s tereotact ic apparatu s that he developed in 1 9 4 9  
(Le ks e l l  1 9 4 9 ) and a col l imated 2 0 0  k i l ovo l t  x - r ay tube . 
T h i s  a p p a r a t u s  a l l owe d t he be ams t o  e n t e r  t he b r a i n  
throughout the convexity o f  the s ku l l  and converge upon t he 
targeted structure (Lekse l l  1 9 5 1 ) .  
Pre sent ly , the term radiosurge ry is u s ed to de s c r ibe a 
noninvas ive procedure us ing a s ingle f ract ion of  radiat ion 
that c an u s u a l ly be performed on an outpatient bas i s . The 
purpos e of r ad io s u rgery i s  to d e l ive r a high dos e o f  
radiation to an intracerebral target without the expos ure o f  
ad j acent normal tis sue to c l in ic a l ly s ign i f ic ant do s e s  o f  
rad iat ion . Mos t o f  the c e rebral neop l a s ms t hat have bee n 
t re ated wit h rad io s urgery are recurrent or inoperab l e . A 
t umo r is con s idered to be inope rab l e  i f  it is d e e p l y  
l oc a l i z e d , o r  i f  t h e  p a t ie nt ' s  c o n d i t i o n  (e x a mp l e , 
re s piratory or c ard iac disease ) prec lude craniotomy (Lars on 
1 9 9 0 ) . The two most  widely used devices for radios urge ry are 
the gamma knife and the l inear accelerator . The gamma kni f e  
u s e s  gamma radiation emitted by the beta dec ay of  cob a l t - 6 0 . 
The l inear acc e l erator produce s x - rays by mic rowave power 
(Bova 1 9 9 0 ) . Both devices have been used to treat benign and 
ma l ignant brain tumors s u c h  as : me ning ioma s , meta s t a s e s ,  
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anap l a s t ic a s t rocytomas , and g l iob l a s toma mu l t i f ome . The 
ma j o r i ty of the t r e a t me n t s h ave b e e n  f or v a s c u l a r  
ma l f o rmat i o n s  s u c h  a s  a r t e r iovenou s ma l f o rmat i o n s  a n d  
angiographically occult vascular mal formations ( Larson 1 9 9 0 ) . 
A r t e r i o v e n o u s ma l f o r m a t i o n s  ( AVM ) a r e  f i s t u l o u s  
communicat ions between cerebral arte ries and veins ( Okaz aki 
1 9 8 9 ) . Addit ional informat ion concerning AVM may be found on 
page 6 8 . 
The general protocol involved with treatment with either 
the gamma kn i f e o r  l i n e a r  ac c e l e r a t o r  is s imi l a r . A 
stereotactic frame is attached to a pat ient ' s  head us ing fou r  
p i n s  placed c ircumf rentially 1 "  above the supraorbital l ine . 
The regions where the pins are placed are inj ected with 1 0  cc  
o f  l oc al ane sthet ic ( l idoc aine- 1 %  and epinephrine- O . S% ) . If 
an arter iovenou s mal f ormat ion i s  being tre ated , b i p l a ne 
angiography o f  the ma in ve s s e l s  s upplying the l e s ion i s  
c onducted . Th i s  i s  f o l l owe d b y  a n  e n h anced C T  s c an , 
per formed with a CT l oc a l i z ing frame attac hed to t he head 
r ing . A s e rie s  o f  1 . S mm transve r s e  CT s l ic e s  are t aken 
throu gh the les ion . For brain tumors , an enhanced CT and or 
a n  M RI i s  t a ke n ( Sh i e l d s  e t  a l . ,  1 9 9 3 ) . P r ior t o  the 
deve lopment o f  computed tomography in the 1 9 7 0 s and magnet ic 
re sonance imaging in the 1 9 8 0 s , radiosurgical procedures were 
dependent upon the loc a l i z ation of tumors via angiography or 
s ku l l  roentgenography ( Luns ford and Kondz iolka 1 9 9 3 ) . 
After the imag ing te s t s  have been conducted , a t e am 
c o n s i s t i n g  o f  n e u r o s u r g e o n s , r a d i a t i o n  o n c o l o g i s t s , 
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n e u r o r ad io l o g i s t s , and me d ic a l  phy s ic i s t s  g e n e r at e s  a 
treatment plan . The treatment plan is devised u s ing computer 
s o f tware and t he data obtained from the imaging te s t s . The 
vo lume of  the l e s ion or brain tumor and its s tereotac t ic 
c o o r d inate s are d e t e rmine d . The n e u r o s u r g e o n  a n d  t he 
rad iat ion oncologi st determine t he radiat ion dos e . Is odo s e  
distribut ions and the characteristic s  o f  t he treatment arc s 
are determined by t he treatment planning sys tem ( S hields et 
al . ,  1 9 9 3 ) . 
LINAC Radio s urgery 
During the 1 9 5 0 s , l inear ac c e l erator s ( L INAC ) we re 
deve loped s imu l t aneou s ly in t he United St ates and i n  t he 
United Kingdom . L inear accelerators accelerate electrons to 
near the speed of  l ight . Microwave s with f requenc ie s in the 
3 -GH z range are used to accelerate the electrons which take s  
p l ac e  on a wave guide . The elec trons are in j ected onto t he 
mic rowave s at an energy of  between 3 0  to 5 0  kilovolt s , which 
i s  roughly 3 0 %  o f  t he s peed o f  l ight . The wave gu ide 
concentrates the electrons onto a portion o f  the wave whe re 
they can be most e f f ic iently accelerated . The maximum energy 
of t h i s  ac celeration is depende nt upon t he des ign o f  t h e  
l inear acce lerator . Energies ranging from 4 MV ( 9 9 . 5 % of  t he 
s peed of  l ight ) to 2 5  MV ( 9 9 . 9 7 %  o f  the s peed of  l ight ) are 
commonly used . The e lec trons are t hen focu s ed onto a he avy 
metal target . The e l ectrons lose e ne rgy as they c ome into 
contact with the he avy metal target . The ma j or ity o f  the 
energy is lost as heat , but there is an element o f  radiat ive 
l o s s . The radiat ive l o s s o f  the e lectron ' s  energy i s  a 
re s u l t  o f  an interact ion between the high ve loc ity e lectrons 
a nd the l arge nuc l e i  of the he avy met a l  t a r ge t . T h i s  
inte r ac t ion produce s a de f lect ion o f  t he e l e c t ro n  a n d  a 
subs equent change in its accel erat ion . The re s u l t  o f  t h i s  
radiat ive los s is t h e  emis s ion o f  x- rays or photons . The x­
ray s  are focu sed by pr imary and sec ondary c o l l imators ( Bova 
2 0  
2 1  
1 9 9 0 ) . 
L inear acce lerators are t he mos t  c ommonly u s ed device s  
in conventional rad iothe rapy . A l ine ar accel e rator cons i s t s  
o f  a gantry which hou ses the photon produc ing appratus and a 
couc h wh ich is u s e d  to pos ition the patient . Du r in g  t he 
tre atme nt proce s s , the gantry rot ates around the pat ient 
de l ivering the prescribed dose of  radiation . S ince they have 
been in use for decades , l inear acce lerators are des igned and 
produced to meet ve ry stringent standard s (Friedman et a l . ,  
1 9 9 2 ) . 
In February o f  1 9 8 6 , doctors at the Brigham and Wome n ' s  
H o s p it a l  in Bo s ton t reated the f ir s t  rad io s u r ge ry pat ie nt 
with a mod i f ied 6 MeV l inear acc e l erator (Al exander and 
Leo f f ler 1 9 9 2 ) . The very f irst patient treated was a 3 1  year 
old woman wit h a l e f t  motor s t r ip AVM (Alexander , pers onal 
communic at ion ) .  Lut z a n d Wins ton (1 9 8 8 ) devel oped var iou s 
mod if ications to t he Bos ton l inear accelerator that enab l ed 
its u s e  in treating smal l ,  prec isely loc ated les ions (0 . 5  t o  
8 cc ) within the brain . They developed a col l imat ion sys tem 
(Figure 1 )  that enabled the col l imators to be placed c l o s er 
to the is ocenter (approximately 2 3  cm ) than the convent ional 
l inear accele rator (7 0 cm ) . The convent ional co l l imato r  
s y s t em wa s i n a d e q u a t e  f o r r ad io s u r g e r y  b e c a u s e  s ma l l  
movements o f  the radiat ion s ource wou ld re s u l t  in magn i f ied 
movements of  the beam at the isocente r . The newly dev i s ed 
c o l l imator  sys tem wa s de s igned to accept one c o l l imator 
ins ert rang ing from 2 . 5  mm to 3 0  mm in 2 . 5  mm inc reme n t s  
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( Figure 2 ) . This would enable a very prec ise enclos ure of  t he 
target wit h i n  the i s odose l ines . During tre atment , the 
patient ' s  body is supported by the couch whi l e  the head i s  
supported b y  the Brown Robe rts We l l s  ( BRW ) f l oor s t and v i a  
t h e  BRW head r i n g  ( Figure 3 ) . The s tand i s  mounted to the 
plate o f  the couch floor bearing . This sys tem enables rapid , 
ac cu rate , rigid , and reproduc ibl e  s etups . The s tand has a 
mec hanism which enables the patient ' s  head to be moved to t he 
des ired cartes ian coordinates ( antero-pos terior , latera l , and 
vert ic a l ) .  The deve l opment of t he Gi l l  T homa s C o s s m a n  
re l oc atable h e a d  holder  ( Figure 4 )  a l l ows f r ac t io n a t e d  
s t ereotac t ic rad i o s u rgery to be pe r f ormed . Du r i n g  t he 
dif ferent f ractions , the accuracy o f  the head hold pos it ion 
can be checked us ing a depth helmet and a depth probe with a 
mil l imeter scale (Figure 5 ) . The BRW sys tem can be u s ed in 
con j unction with a BRW local izer frame to prec isely ident i f y  
t h e  t a r g e t  via C T . L oc a l i z ation o f  a n  arter iove n o u s 
ma l formation is via angiography us ing a s pec ially de s igned 
l oc a l i z er box and the BRW loc a l i z e r  sys tem . The ima g i n g  
procedure s allow for the prec ise stereotact ic localiz at ion o f  
the intracerebral target . 
A very important r e s u l t  o f  t he l inear acc e l e r at o r  
mod i f ic at ions deve loped b y  Lut z a n d  Win s ton (1 9 8 8 ) i s  t h e  
c apab i l ity to ve r i f y  t he al ignment o f  the setup . A s tee l 
b a l l  i s  u s ed to repre s ent the intrac ran i a l  t arget at the 
exact isocenter . The steel bal l is local ized in the prec i s e  
c arte s ian c oordinate s as t h e  pat ient ' s  l e s ion ( F igure 6 ) . 
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The ver i f ic ation procedure expo s e s  f ilm to t he l inac x - r ay s  
at a c omb inat ion o f  a t  l e a s t  e i ght p o s s i b l e  gantry a n d  
turntable pos it ion s . If the steel b a l l  is cente red wit h i n  
the acceptab le l imit s o f  a l l  e ight expo s u re s , it c a n  be 
conc luded that setup is correct and properly al igned ( Figure 
7 ) . The ver ificat ion procedure can detect such errors a s : a 
mis al ignment of the col l imator insert or the BRW stand , or an 
inc orrect setting o f  t he cartes ian coordinates . Bas ic a l l y , 
t h i s  ve r i f ic at io n  procedure c he c k s  a l l a s pe c t s  o f  t he 
treatment except loc a l i z at ion of  the les ion via compute r i z ed 
tomography or angiography ( Lut z and Winston 1 9 8 8 ) . 
Lutz and Wins ton ( 1 9 8 8 ) a l s o  calculated the accuracy o f  
t h e  ima g i n g  s ou r c e s  a n d  t h e  prec i s i o n  o f  t h e  l i n e a r  
acc e l e r ator beam . They f ound t h at l oc a l i z at ion v i a  C T  
re su lted in an error o f  1 . 3  ± 0 . 7  mm .  Angiography produced a 
s ma l l e r  mar g i n  o f  e r r o r  o f  0 . 2  ± 0 . 2  mm . The l ine a r  
accelerator produced a n  isocenter loca l i z at ion error o f  0 . 4 8 
± 0 . 1 6 mm. 
Other linear accelerator centers have made change s that 
decreased the is ocenter loc a l i z ation error produced by the 
L INAC . At the Univers ity of  Florida , Friedman et al e ( 1 9 9 2 ) 
de s i g n e d  a s y s tem that produced a l oc a l i z at io n  e r r o r  
c omparable to any e x i s t ing radio s u rgic a l  s y s tem . D u r i n g  
tre atment , the p re s c r ibed t reatment arc i s  produced b y  
rotating the gantry from a vertical t o  a horizontal pos ition . 
Due to the we ight o f  the gantry , this movement c au s e s  a 
s agging o f  the gantry re s u l t ing in a mis a l ignment o f  t h e  
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col l imator . This mis a l ignment wil l re s u l t  in a photon beam 
t h a t  is f oc u s ed be l ow t he i s oc e nte r . A l s o , e r r o r  i s  
introduced into the tre atment p l a n  whe n  t he patient i s  
repo s it ioned between arc s . T o  solve t he s e  problems , t he y  
devised a sys tem o f  high- prec is ion bearing s . The bearing 
sys tem for the gantry and the patient rotational device were 
mec hanical ly coupled to e n s ure t hat both rotational axe s 
coinc ided . Al s o , another bearing system was devised for the 
c o l l imator that e f fective ly separated it from the gantry and 
avo ided any trans fer of torque between t he gant ry and the 
col l imator . The three bearing systems produce an i s ocenter 
accuracy o f  0 . 2  ± 0 . 1  mm (Fr iedman et a l . ,  1 9 9 2 ) . This i s  
approximate ly 1 %  o f  the average beam diameter u s ed in l inear 
accelerator radios urgery (Bova 1 9 9 0 ) . 
The treatment planning phase is the mos t  crit ical aspect 
o f  r a d i o s u r g e ry . The t r e a t me n t  t e am c o n s i s t s  o f  
neurosurgeons , rad iat ion oncologis t s , rad iat ion phys ic is t s , 
and neuroradiologists . There are many ob j ective s which mu s t  
b e  met during the pl anning phase . One o f  the mos t  important 
dec is ions to be made i s  what dos age s hou ld be u s ed . T h i s  
determination is general ly made b y  t h e  neuro s urgeon a n d  t he 
r a d i a t ion onc o l o g i s t  (P od gors a k  1 9 9 2 ) . The rad i a t i o n  
o nc o l o g i s t  may r e l y  u p o n  pa s t  e xpe r i e n c e  o r  p ub l i s he d  
c l inic al  trials t o  determine the dos age . When pre s c r ibing a 
dos a ge , f actors such as the target ' s  s h ape and volume , t he 
c o l l imato r  s i z e , a nd do s e  inhomoge neity are c o n s idere d . 
Al s o , t he risk of  brain nec ros is is an important f actor whe n  
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determining radiat ion dos age . 
Dose inhomogeneity plays a c rucial role in the res u l ting 
compl ications of  radios urgery . The total dose inhomogene ity 
( TD I )  is de f ined as the di f ference between the maximal tumor 
do se and the minimal tumor dose ( Nedz i et a l . ,  1 9 9 1 ) . Do s e  
inhomogeneity may result from treating larger o r  irregu larly­
s h aped t a r get s . The c o l l ima t o r s  u s e d in both l in e a r  
accelerator and gamma knife radiosurgery produce a s pheric a l  
dos age d i s t r ibu t ion . S ome l e s ions may n o t  c o n f o rm t o  a 
s pheric a l  s hape ; there fore , mu l t iple isocenters can be u s ed 
to more fully c ircumscribe the target . In L INAC radiosurgery , 
mu l t iple is ocenters are created by moving the convergence o f  
radiat ion beams a predetermined distance between treatme nt s . 
This wil l  cause an overl apping o f  radiat ion f ields . Certain 
regions of  the treatment volume wil l  rece ive more than two to 
three time s the dose o f  the s ingle is ocente r ( Nedz i et a l . ,  
1 9 9 1 ) . Inhomogene ity may s eem to be an ins ign i f ic ant f actor 
i f  the tumor vo l ume conta ined only tumor c e l l s , but s ome 
tumors and treatment de s igns include normal t is sue within t he 
target volume . Nedz i et al e ( 1 9 9 1 ) treated 6 4  recurrent or 
inoperable intrac ranial tumors in 60 patients (4 0 primary , 2 4  
metastatic ) with a 6 MeV l inear accelerator . They determined 
that tumor dose inhomogeneity was the mos t  s igni f ic ant f actor 
re l ated to compl ic at ions due to toxic ity . Other var iab l e s  
that we re h ighly correl ated with tumor d o s e  inhomogene ity 
inc luded : max imum tumor dos e , number o f  is ocenters , maximum 
normal  tissue dose , and tumor volume . They determined that a 
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l ow r i s k  o f  c ompl ications existed for l e s ions with vol ume s 
l e s s t h a n  1 0  c c  treated with a s in g l e  i s oc e n t e r  with a 
maximum dose of  2 5  Gy and a minimum tumor dos e  inhomogene ity 
of less than 1 0  Gy . 
During L INAC radiosurgery , the tumor is s urrounded by a 
beam o f  x- rays whose diameter is dete rmined by t he s iz e  o f  
the c ircu lar col l imator . Col l imator sizes range from 5 to 4 0  
rom in diameter ( Friedman et al . ,  1 9 9 2 ) . The photon beams al l 
inte rsect at the target f rom a number o f  noncopl anar a rc s . 
This c auses the tumor to be surrounded in three-dimens ions by 
the photon beam , usually in the s hape of a s phere ( Podgo r s a k  
1 9 9 2 ) . T h e  geometric c e nter o f  t he tumor i s  the u s u a l  
is ocenter , i . e .  the point where 1 0 0 %  o f  the pre s c r ibed do s e  
i s  concentrated . Moving away f rom t he geometric center o f  
the tumor toward t he out lying normal t i s s ue , t here i s  a 
de c re a s e  in t he radiation dose . The c o n c e nt r a t i o n s  o f  
rad i a t i o n  t h roug hout t h e  tumor a n d  n o rma l t i s s ue i s  
repre sented by isodos e l ines . During the planning procedure , 
there is a superpos it ion of  isodose distributions on the CT , 
MRI , or angiograph ic images whic h have been trans fered to a 
computer via magnetic tape ( Figure 8 ) . This enables the team 
to view in three d ime n s ions the path o f  the photon b e am 
( Podgors ak 1 9 9 2 ) . The arcs are def ined in terms of  arc - s tart 
a n g l e , a r c - e nd a n g l e , and c o u c h  a n g l e . E a c h  a r c  may 
c ontr ibute an arbit rary fraction of the tot al dos e t o  the 
t arget . If t hey f ind that t he beam i s  go ing t hrough a ny 
c r i t i c a l  or do s e  s e n s it ive s t ructures s u c h  as the optic 
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ne rves and chias m ,  eye s , area pos trema , or the brain s tem , 
they must modify the arc s ( Alexander and Loe f f ler 1 9 9 2 ) . 
The pre s e nce o f  a s harp dos e f a l l - o f f  imme d i at e l y  
outs ide o f  the target i s  another ob j ective that mu st b e  met . 
T h i s  e n ab l e s  o n l y  the t a rget t o  r e c e ive b i o l o g i c a l l y 
s ig n i f icant do s e s  o f  radiation whi l e  the out lying norma l 
b r a i n  t i s s u e i s  s p ared f rom h i g h  d o s e s  o f  r a d i a t i o n  
( Podgorsak 1 9 9 0 ) . 
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Figure 1 :  L inear Accelerator Coll imat ion System (Courte sy of 
Radionic s Inc . , Burl ington , Mas sachusetts ) .  
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Figure 2: Col l imator Ins ert s (Courtesy of  Rad ionic s Inc . , 
Burl ington , Mas sachusetts ) .  
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Figure 3: Brown Robert s Wells Floor Stand and Head Ring . 
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Figure 4: Gill Thomas Cosman Relocatable Head Holder. 
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Figure 5: Ac curacy o f  t he H e ad Hol der p l a c eme nt being 
chec ked via a Depth He lmet and a Depth Probe . 
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Figure 6: LINAC Verification Proced ure (Courtesy of 
Radionics Inc. , Burlington, Massachusetts). 
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Figure 7: X- r ay f i lm of 9 arc s t a ke n  during t he L INAC 
Verification Procedure . 
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Figure 8: Is od o s e  D i s t ribu t i o n s . Ye l l ow - re d  c o l or 
repre s e nt s  the 8 0 %  is odose l ine . Green re pre s e nts the 5 0 %  
i s odo s e  l i ne (Court e s y  o f  Rad ionic s In c . , Burl i n gt on , 
Mas s achusetts ) .  
Theor e t i c a l  Phys i c s  o f  the Int e r a c t ion Betw e e n  
T i s sue and Photon s 
As the photon be am penetrate s tis s ue , there is a rapid 
ris e in dos age from a re lative ly low value at the surface o f  
the s kin toward a max imum dos age re ac hed a t  a dept h te rmed 
the d�x. The dmax repres ents the depth at wh ich the maximum 
dos age is reached . The region between the s ur face and d max is 
termed the dose buildup region . Beyond the depth of maximum 
dos age , there is an exponent ial dec rease in the dos age . The 
t i s s ue build-up region depend s upon the s ource . X- rays in 
the orthovo ltage range do not have a t i s s ue bu ildup regio n ; 
their max imal dos age occ u r s  at the s ur f ace . X-rays with 
s ource s of  6 MV and 10 MV have build-up regions of 1 . 5 cm and 
2 . 5  cm respect ively . Gamma rays produced by the beta dec ay 
of  60CO have a dose bu ild-up region of 0 . 5  cm . Photons in the 
megavoltage range , there fore , exhibit a s kin sparing e f fect 
(Podgors ak 1 9 9 2 ) . 
The dominant interaction that occurs between the photon 
and the t is sue medium is the Compton interaction (Khan 19 9 4 ) . 
The p hoton interacts with the free electrons in the abs orbing 
medium . The photon c o l l ides wit h an outer l oo s e ly bound 
orbital e l ectron . This s c atte rs the inc ident photon and 
impart s a kinetic e nergy upon the e l ec t ron . The s e  h i g h  
energy Compton e lectrons a r e  s c atte red toward t he forward 
36 
3 7  
direction , whic h impart s a s kin sparing e f fect (We ic h s e lbaum 
et a l . ,  1 9 9 3 ) . There is a point in depth where the e lectrons 
created near the surface approach the end of the ir range . At 
the s ame point , t he decrease in the numbe r o f  photons wil l  
re s u l t  in a dec rease in newly created high-energy electron s . 
The depth where the el ectron dens ity wil l  reac h  it s maximum 
is known at the dmax or maximum dose . Al l other point s within 
the medium will have a lower electron dens ity and there fore a 
lower dose , cal led the fall-of f region (Bova 1 9 9 0 ) . 
llBoo s t "  ve r s u s  Sing l e  Do s e  Radi o s urg ery 
Rec e nt l y , there h a s  been s ome debate regard i n g  t he 
met hod by wh ich t he pre s c r ibed rad iat ion dos age s ho u l d  be 
del ivered to mal ignant brain tumors . Us ing rad iobio l ogic a l  
t heory , Hall and Brenner (1 9 9 3 ) bel ieve that the del ivery o f  
radiat ion i n  a s ingle dose t o  a mal ignant brain tumor wil l  
re s u lt i n  a s ubopt ima l the rapeutic rat io . Howeve r ,  they 
b e l i e v e  t h a t  t r e a t me n t  of b e n i g n  l e s i o n s  s u c h  a s  
arter iovenou s mal format ions i s  opt imal under s ingle f ract ion 
radiat ion dose treatment . The ir reasoning is based upon two 
di f f erent radiobiologica l princ iples . Ma l ignant tumors o f  
a l l  s iz e s  cont a in s ome port ion o f  hypoxic c e l l s . Hypoxic 
c e l l s  are re s is t ant to kil l ing by e ither X- ray s  or gamma 
r ays . A s ingle f raction o f  radiat ion wi l l  k i l l a l arger 
f r ac t ion o f  the metabo l ic a l ly act ive (r adios ens itive ) t h a n  
the hypoxic cel ls . After irradiation , a large port ion of t he 
tumor is hypoxic . Given a short period o f  time there wil l be 
a re-es tabl ishment of the original proportions of  oxygenated 
and hypoxic c e l l s . This a l l ows many o f  the previou s ly 
hypoxic c e l l s , which have become metabo l ic a l ly active , to be 
kil l ed by a second and s ubs equent f rac t ions of rad i at ion . 
A l t h o u g h  many human tumo r s  h ave b e e n  e r a d i c a t e d  w i t h  
radiotherapy dos e s o f  6 0  Gy given i n  3 0  f ractions , i t  is not 
known whether or not human tumors rexoygenate (Hal l 1 9 9 4 ) .  
Tis s ues  have been c l as s if ied into two d i f f erent c ategorie s : 
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l at e  r e s po n d i n g  a n d  e a r l y  r e s po n d i n g . Art e r i ove n o u s 
mal formations and normal brain t i s sue are s aid to be l at e  
re s ponding t is sues . The e f fects o f  radiat ion are mani f e s t  
weeks t o  months a f te r  the radiation t reatment . Ma l ignant 
tumors are c l as s i f ied a s  early re s ponding t i s s u e s  i n  t hat 
they are af fected within hours or a few days o f  the radiation 
treatment . Due to the dif fering dose-re s ponse re l at ion s hips 
of e a r l y  and l at e  re s pond i n g  t i s s u e s , a f r a c t i o n a t e d  
treatme nt s c hedu le wil l  produce a greater s p aring e f fect o n  
l ate res ponding norma l t i s s ue s  than wou ld a s ingle dos e  o f  
radiation . A f rac t ionated tre atment wi l l  re s u l t  in l e s s 
d ama ge to norma l  b r a i n  t i s s u e  and a gre ater degree o f  
mal ignant tumor ce l l  death than s ingle dose treatment . S ince 
arter iovenou s mal format ions and normal brain tis sue are both 
l at e  re s p o nd i n g  t i s s u e s , t h e re w i l l be no g a i n  i n  
pre f ere ntial k i l l ing o f  the l e s ion and s paring o f  norma l 
t i s s ue via fract ionated therapy (Hal l and Brenner 1 9 9 3 ) . One 
o f  the advantages of s ingle dose radiosurgery is its abil ity 
to kil l radiore s is tant tumors s uch as metastases f rom re nal 
cell s arcoma s and me lanomas . This is bec au s e  radios urgery 
u s e s  a higher s in g l e  dose o f  radiation than f ract ionated 
radiothe rapy . Hall and Bre nner ( 1 9 9 3 ) propo s e d  a s ys tem 
u s ing a noninvas ive reloc atable stereotactic head f rame and a 
t re atment p l a n  cons i s t ing o f  f ive or s ix f rac t ions . They 
bel ieve that keeping t he number of f ract ions low wil l not 
c au s e  a s igni f ic ant decreas e in radiores is tant tumor deat h . 
This protocol incorporates t he advantage s  o f  frac t ionated 
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radiotherapy with a high tumor dose ( Hall and Brenner 1 9 9 3 ) . 
L a r s on et a l . ( 1 9 9 3 ) be l ieve t hat d e s p it e  the two 
rad iobio logica l pr inc iples c ited by Hal l and Brenner ( 1 9 9 3 ) 
there is l ittle to be gained by f ractionat ing treatments for 
mo s t  s ma l l  intrac r a n i a l  t a rge t s . Larson et a l . ( 1 9 9 3 ) 
deve loped a graphical mode l comparing the f ract ionated do s e  
a t  2 Gy pe r f ract ion that i s  requ ired to produce the s ame 
radiobiologic e f fect f or a g iven radios urgical dos e . The 
graph inc luded l ate and early res ponding t i s s u e s . The i r  
r e a s o n i n g  i s  b a s e d  u p o n  t h e  d i f f e r i n g  c ompo s i t i o n  o f  
malignant tumors ( early res ponding t is s ue ) . Mal ignant tumors 
can be embedded wit hin l ate res ponding norma l  t i s s ue as is 
t he c a s e  with low grade a s trocytoma s . The term embedded 
means  that the target c ontains ma l ignant tumor t i s s ue and 
n o rma l b r a i n  t i s s u e . Al s o , ma l i g n a n t  tumo r s  c a n  be 
s u r rounded by l ate res ponding norma l t i s s u e  whic h wou l d  
inc lude GBM and metastases . Within low grade astrocytoma s , 
re s ide norma l g l i a l  c e l l s , neuronal c e l l  bod ie s , axo n s , 
microglia, and blood vessels. With a single treatment dose 
o f  3 0 -4 0  Gy , the malignant tis sue experiences a radiobiologic 
e f fect of 5 0 - 1 0 0  Gy of fractionated radiotherapy . The normal 
t is s ue within the target experiences the radiobiologic e f fect 
o f  1 0 0 - 2 0 0  Gy o f  fract ionated radiotherapy ( La r s o n  e t  a l . ,  
1 9 9 3 ) . Al though Po z z a  et al . ( 1 9 8 9 ) reported a f avora b l e  
therapeut ic rat io in the treatment o f  low grade a s trocytomas 
wit h radios u rgery , few , if  any low grade a s trocytoma s are 
be ing t reated with radiosu rgery in North America ( La r s o n  et 
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a l . ,  1 9 9 3 ) . GBM and met a s t a s e s  f a l l  into t he category o f  
early responding tis s ue s urrounded by late re s ponding norma l  
t i s s u e . There is l ittle i f  any normal brain t i s s u e  wit h in 
the target . During radiosu rgery , t he t arget receive s 2 0 - 4 0 
Gy wh ic h is  radiobiologic a l ly equ ivalent to 5 0 - 1 0 0  Gy o f  
f r ac tionated radiothe rapy . The norma l  brain t is s ue in t he 
areas immediate ly s urround ing t he t arget rec e ive 5 - 1 0  Gy 
during radiosurgery which is radiobiologic a l ly equivalent to 
1 0 - 3 0  Gy of f ract ionated therapy . I n  general , ma l ignant 
tumors t hat are t reated with radiosu rgery are expo s ed to a 
h i g h  d o s e  o f  radiat ion . The s u rrou nd ing norma l  t i s s u e 
receives a s ignif icantly lower dose o f  radiation . 
D i f f er ent LINAC Radiosurgi c a l  T e chni que s 
currently , there are three methods o f  l inear accelerator 
radiosurgery in use ; the techniques vary with regard to t heir 
dos e gradie nt drop -of f s . The degree o f  radiation dos e  drop 
o f f  i s  an imp o r t a n t  c o n s ide r a t i o n  i n  e va l u a t i n g  a 
r a d io s u r g i c a l  s y s tem . Do s e  r e g i o n s  b e l ow 2 0 %  a r e  n o t  
cons idered t o  b e  s igni f ic ant ( Podgors ak et al . ,  1 9 8 9 ) . One 
o f  the goal s of radiosurgery is the depos it ion o f  a high dos e  
o f  radiation t o  the target while s u b j ect ing ad j acent norma l  
t i s s u e  to b iologic a l ly ins igni f ic ant do s e s  o f  radiation . 
podgo r s ak et al . ( 1 9 8 9 ) c a l c u l ated t he dos e drop - o f f s  f o r  
var iou s sys tems bas ed upon a s phe ric a l  target with a 1 c m  
diameter . P lease see Tab le 2 f o r  a comparison o f  t he do s e  
fall-of f s . 
S ingle pl ane rotat ion ( Houdek 1 9 8 5 ) is  almost ident ica l  
t o  the rot at ional technique s u s ed in s t andard rotat i o n a l  
radiotherapy . S ingle plane rotation dif fers in that the dos e  
is  given i n  a s ingle s e s s ion , a s tereot ac t ic f rame i s  u s ed 
f o r  t r e atment , the radiation f ie l d  i s  s ma l l e r , a nd t he 
pat ient is immobilized during therapy . During treatment , t he 
gant ry rotate s around the patient in a 3 6 0 0 arc ( Podgo r s a k  
1 9 9 2 ) . The  do s e  f a l l - o f f s  t h a t  oc c u r  i n  t he p l a n e  
perpendicular to the plane o f  rotat ion are very s teep . From 
the 9 0 %  i s odos e  l ine to the 5 0 % , 2 0 % , and 1 0 %  i s odos e l in e s  
t h e  dis tance s are 2 . 0  mm , 2 . 5  mm , a n d  3 . 0  mm respective l y . 
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However , the dose fall-of f s  in the pl ane o f  rotat ion are very 
s hal l ow .  This is bec au s e  there is an i n f inite numb e r  o f  
paral lel opposed beams . During the 3 6 0 ° rotation , the entry 
pathway for one beam coincides with the exit o f  another beam . 
From the 9 0 %  i s odose l ine to the 5 0 % , 2 0 % , and 1 0 % i s odo s e  
l in e s  t he d i s t a nc e s  are 3 . 5  mm ,  1 4 . 4  mm , and 3 2 . 0  mm 
respectively ( Podgors ak et al . ,  1 9 8 9 ) . 
varying numbers o f  multiple noncopl anar converging arc s 
are in u s e  at many d i f ferent l inear accelerator fac i l it i e s . 
This technique involves a dif ferent treatment couch pos it ion 
for eac h arc wh ich allows the dos e  to be s pread out over as 
l arge a volume a s  po s s ib l e . The arc ang l e s  are u s u a l ly 
smal ler than 1 8 0 ° to avoid paral lel opposed beams . Lut z and 
Wins ton ( 1 9 8 8 ) u s ed a s y s tem of 4 c onve rging noncop l a n a r  
arc s . One arc ( couch angle = 0 ° ) is in t h e  transverse p l ane 
from 0 = 5 0 ° to 0 = 3 1 0 ° . Three 1 0 0 ° arc s were produced with 
couch angles of 9 0 ° , +4 5 ° , and _ 4 5 ° . The s teepe s t  dose f a l l ­
o f f s  f rom the 9 0 %  i s odo s e  l ine to the 5 0 % , 2 0 % , a n d  1 0 %  
isodos e l ine s we re 2 . 1  mm ,  4 . 0  mm ,  and 7 . 6  mm re s p e c t ive ly . 
The s hal lowe s t  dose f a l l -o f f s  f rom t he 9 0 %  i s odose l ine to 
the 5 0 % , 2 0 % , and 1 0 %  isodose l ines were 2 . 9  mm ,  8 . 0  mm, and 
1 9 . 3  mm res pective ly ( Podgor s ak et al . ,  1 9 8 9 ) . Hartmann et 
al e ( 1 9 8 5 ) u se d a sys tem of up to 1 1  noncopl anar c onverg ing 
arc s f or t he i r  tre atment protoco l . Depe n d i n g  u p o n  t he 
pos it ion of the treatme nt couch , the arc angles were from 2 0 ° 
to 1 6 0 ° or 2 0 0 ° to 3 4 0 ° . The steepe s t  dos e  f a l l - o f f s  f rom 
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the 9 0 %  is odose l ine t o  the 5 0 % , 2 0 % , and 1 0 %  i s odose l in e s  
we re 2 . 3  mm , 4 . 6  mm , a n d  7 . 3  mm , re s pec t ive ly . T h e  
s h a l l owe s t  dos e  fal l - o f f s  f rom t h e  9 0 %  isodo s e  l ine t o  t he 
5 0 % , 2 0 % ,  and 1 0 %  isodose  l ines were 2 . 6  mm ,  6 . 9  mm ,  and 1 1 . 4  
mm ( Podgors ak et al . ,  1 9 8 9 ) . 
Podgor s ak et al e ( 1 9 8 8 ) deve loped a s y s tem o f  l inear 
ac c e l e rat or  r a d i o s u r g e ry t e rme d  dynamic r a d i o s u r g e r y . 
Dynamic radiosurgery incorporates continuous and s imu ltaneous 
rotation of the gantry and the treatment couch throughout the 
t re atment procedure . The gantry rotates 3 0 0 ° f rom 3 0 ° t o  
3 3 0 ° , and the treatment couch rotates 1 5 0 ° , f rom 7 5 ° t o  _ 7 5 ° . 
The mechanic s o f  dynamic radiosurgery enable the entry points 
o f  all be ams to l ie in the uppe r hemisphe re wh ile t he be am 
exit po int s re s ide in t he lower hemisphe re . Th is e n s u r e s  
that there are never para l l e l  oppo s e d  be ams produc ed which 
wou ld degrade the s teep dose f a l l -o f f  outs ide of the target . 
The s teepe st dos e  f a l l - o f f  for this tec hnique f rom the 9 0 %  
i s odose l ine to the 5 0 % , 2 0 % , and 1 0 %  i s odos e  l ines was 2 . 0  
mm ,  3 . 8  mm ,  and 5 . 0  mm ,  re spectively , which is qu ite s imil ar 
t o  the gamma u n it value o f  2 . 0  mm , 3 . 5  mm and 5 . 0  mm , 
r e s pec t ively . The s h a l l owe s t  d o s e  f a l l - o f f  f o r  dynamic 
rad io s u rgery f rom the 9 0 %  isodose l ine to t he 5 0 % , 2 0 % , and 
1 0 %  i s od o s e l i n e s  wa s 2 . 5  mm , 7 . 7  mm , and 1 8 . 0  mm 
re spectively . Respective gamma unit values were 4 . 0  mm ,  1 2 . 0  
mm,  and 2 2 . 0  mm ( Podgors ak et al . ,  1 9 8 9 ) . 
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Fa l l -O f f  Dis t ance s  from the 9 0 %  I s odose Line ( Table 2 )  
Radiosurgical 
TechniQue 
S ingle plane : 
Steepest 
Shallowest 
4 Noncoplanar 
Arc s : 
Steepest 
Shallowest 
1 1  Noncoplanar 
Arc s : 
Steepest 
Shallowest 
Dynamic : 
Steepest 
S hallowest 
Ganuna Knife : 
Steepest 
Shallowest 
5 0 %  
2 . 0  nun 
3 . 5  nun 
2 . 1  nun 
2 . 9  nun 
2 . 3  nun 
2 . 6  nun 
2 . 0  nun 
2 . 5  nun 
2 . 0  nun 
4 . 0  nun 
Isodose Line 
2 0 %  
2 . 5  nun 
1 4 . 4  nun 
4 . 0  nun 
8 . 0  nun 
4 . 6  nun 
6 . 9  nun 
3 . 8  nun 
7 . 7  nun 
3 . 5  nun 
1 2 . 0  nun 
1 0 %  
3 . 0  nun 
3 2 . 0  nun 
7 . 6  nun 
1 9 . 3  nun 
7 . 3  nun 
1 1 . 4  nun 
5 . 0  nun 
1 8 . 0  nun 
5 . 0  nun 
2 2 . 0  nun 
M a l ignant G l ioma s 
Anap l a s t ic a s t rocytoma s ( WHO Grade I I I ) and GBM ( WH O  
Gr ade IV ) a r e  ma l ignant tumors wit h vary i n g  d e g r e e s  o f  
hyperc e l lu larity and changes i n  blood ve s s e l s . The ir c e l l s  
d iv ide rap i d l y , a n d  they a r e  c h a r ac t e r i z e d  b y  t h e i r  
inf iltrat ing nature ( Schif fer 1 9 9 3 ) . Tumors c e l l s  have been 
verif ied histopathologically at several centimeters away f rom 
a l e s io n  d e f ined by imaging t e c h n i qu e s  ( Al e xande r a n d  
Loe f f l er 1 9 9 2 ) . Howeve r ,  a pat ient ' s  death i s  u s u a l ly 
att r ibutable to the inabil ity to l oc a l ly c ontrol t he t umor 
( Wa l l ner 1 9 8 9 ) . Regardle s s  o f  subsequent therapy , the median 
survival for patients who have undergone an exc is ion of a GBM 
i s  twe lve months . P at ients with AA have a median s u rviva l 
rate of 2 7  months ( Chang et al . ,  1 9 8 3 ) . 
Studie s have been conducted to determine the e f f ic acy o f  
radiosu rgery as a boost to conventional radiotherapy for AA 
and GBM . Loe f f le r  et al e ( 1 9 9 2 ) u s e d  L I NAC radio s u rg e ry 
a fter the pat ients had undergone surgical res ection or biopsy 
and f ract ionated external beam radiotherapy . They treated 3 7  
patients , 2 3  who were diagno sed with GBM and 1 4  who had a n  
AA . Partic ipant s of  the s tudy were s e lected upon the bas is 
of s trict c riteria : 1 )  a minimum Karno f s ky performance s core 
of 7 0 % , 2 )  a radiographic al ly we l l -def ined tumo r ; and 3 )  a 
l e s ion no l arger t han 4 c m  in greate s t  d iame t e r  a f te r  
s u rgery . Twe nty patient s u nderwe n t  a s u rg i c a l  re s e c t i o n  
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proc edure , and 1 7  pat ient s underwe nt biop s y . Al l o f  t h e  
p a t i e n t s  we re s u b j e c t e d  to c o nv e n t i o n a l  r a d i ot h e r a py 
beginning 2 wee ks after s u rgery . E ac h  pat ient rec e ived a 
total o f  5 9 4 0  cGy given in 3 3  fractions . Approximately 2 to 
4 weeks after radiotherapy , radiosurgery was performed . The 
med i a n  tumor volume was 4 . 8  c c  wh ich inc l uded a 2 - 4  mm 
margin . The median fol low-up per iod for t he study wa s 1 9  
mo n t h s . A l mo s t  a l l  o f  t h e  p a t ie nt s h a d  t o  u n d e r g o  
corticos teroid the rapy a t  s ome point a fter radios urgery due 
to symptoms re s u l t ing from per itumora l edema . Fou rteen o f  
t he 3 0  pat ient s who were f o l l owed for over one year s t i l l  
required corticosteroids o n  a n  intermittent bas is . Patient s 
who we re diagno s e d  wit h GBM had a median s u rviva l o f  2 6  
months . At the t ime o f  publ i s hing , t he median s u rvival for 
pat ient s with AA had not been reached . As o f  June 1 9 9 4 , the 
addit ion o f  35 AA pat ient s treated by t he radio s u r g i c a l  
p r otoc o l  h a s  not a l l owed f o r  t h e  me dian s u rvival t o  be 
reached ( Loe f f ler , pers onal communication ) .  Among the 23  GBM 
pat ie n t s , 1 6  were al ive and 1 5  were d i s ea s e  f ree . The 7 
deaths cou ld be attributed to failures at the margins o f  the 
treatment vo lume and l oc al progre s s ion o f  the tumor with in 
the treatment volume . Among the patients diagnosed with AA , 
2 d ied . One death wa s attr ibuted to b u l b a r  amyot roph ic 
lateral s c leros is while the other was due to a s e i z ure in a 
pat ient who had refused ant iconvu l s ant medication . E leven o f  
t h e  surv iving patie nt s with AA we re fol lowed for o n e  year , 
and t h ey a l l  rema ined f r e e  o f  d i s e a s e  progre s s io n . T h e  
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aut ho r s  conc luded t hat t he u s e  o f  L I NAC radio s u rgery a s  a 
boo s t  treatment for GBM and AA compared f avorably wit h  other 
therapies . 
Trea tment o f  Bra i n  Meta s t a s e s  w i th L INAC 
R adio s urg ery 
A l  though s u r g i c a l  r e s e c t io n  f o l l owe d by r ad i a t i o n  
t he r apy i s  the met hod o f  t reatment f o r  s o l itary c e re b r a l  
me t a s t a s e s , approx imat e l y 6 0 % - 8 0 %  o f  pat ie n t s  are n o t  
s u itable f o r  surgery . The c riteria that mu s t  be met f o r  a 
pat ient to undergo surgery inc lude : s o l itary and surgic a l ly 
acce s s ib l e  metas t a s e s , l imited s y s temic d i s ea s e , and good 
Karno f s ky per formance statu s . Radiosu rgery may be an opt ion 
for pat ient s who have s ingle or mu ltiple cerebral met a s t a s e s  
t hat are recu rrent , pe r s i s t ent , radiore s i s tant , o r  are 
i n ac c e s s ib l e  by s u r ge ry . Mos t c e re b r a l  me ta s t a s e s  a r e  
amenable to radiosurgery because they are u s u a l ly spheric a l , 
we l l  c i rcums c r ibed , and have radiograp h ic a l ly d i s t i n c t  
e n h a n c i n g  mar g i n s . Al s o , mic r o s c op ic i n f i l t r a t i o n  o f  
surrounding normal brain tis sue i s  inf requent ( Engenhart et 
al . ,  1 9 9 3 ) . 
S tu rm et a l e ( 1 9 8 7 ) s t ud ied the e f f e c t s  o f  L I NAC 
radio s urgery on radiore s is tant and deeply local ized cerebral 
metastases in seven pat ients . S ingle dos es o f  2 0 - 3 0  Gy were 
given at the 8 0 %  i s odose l ine . During t he f o l l ow-up per iod 
of greater than three month s ,  a l l  of the pat ients p re s e nted 
an arrest in the growth o f  the tumor and in four cases , t here 
was a shrinkage in the tumor mas s . I n  al l of the patients who 
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had edema , there was reduction o f  t he edema wh ic h could be 
d i rec t ly att r ibuted to the irrad i at ion . There we re no 
recurrences in the growth o f  the irradiated tumors and t here 
were no reported s ide e f fects . Al l pat ient s , showed c l inic a l  
and radio l ogic a l  improveme nt wit h i n  the f i r s t  few d a y s  
fol l owing irradiat ion . A t  the t ime o f  publ ic at ion , mos t  o f  
the pat ient s ( f our ) d ied d u e  to a genera l i z ation o f  t h e  
metastases o r  the occurrence of other brain metastases . 
Loe f f l e r  et a l e ( 1 9 9 0 ) report ed t he re s u l t s  o f  a 
c l inic a l  inve s t igat ion on the treatme nt o f  rec urrent brain 
metastases with LINAC radiosurgery . The ir 1 8  pat ients had a 
Karno f s ky performance s core greater than or equal to 7 0  a nd 
no evidence of systemic disease . Al s o , the pat ie nts mu s t  
have f ailed prior radiotherapy and s urgery . The volume s  o f  
the treated les ions were les s than 2 7  cc . The median dos e  o f  
prior whole-brain radiotherapy was 3 6  Gy with a mean interval 
between rad iotherapy and radiosurgery o f  1 0  months . O f  t he 
2 1  les ions that were treated , there was e ither a dec re a s e  in 
s i z e  or a s ta b i l i z at ion o f  t h e i r  cont ras t - e nhancing vol ume . 
A l s o ,  t h e  ma j or ity o f  the pat ie nt s s howed a n  imp rove d 
neurological condit ion and were able to be discontinued f rom 
s t eroid therapy . Lethargy , headache , nau s e a , and vomit ing 
whi c h  are  cons idered to be c l inic a l  s ymptoms o f  inc re a s e d  
intrac ranial pre s s ure , were e l iminated o r  dec reased within 6 
we e k s  o f  r a d io s u r gery . S u rp r i s i n g l y , de s p it e  p r e v i o u s 
exposure to rad iotherapy there were no s igns o f  s ymptoma t ic 
radionecros is in any of the patients . 
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The c l in ic a l  inve s t igations o f  Loe f f ler e t  al e ( 1 9 9 0 ) 
and S t rum et a l e ( 1 9 8 7 ) had re l at ive ly s hort f o l l ow- u p  
pe r i od s . E n ge nhart et a l e ( 1 9 9 3 ) c o nducted a l on g - t e rm 
fol low-up of 5 7  pat ient s with inoperable brain metastases who 
were treated with LINAC radiosurgery . The mean follow-up was 
8 . 6  months ( range , 1 - 5 6  months ) .  Complete remi s s ion wa s 
f ound in 2 0 % , partial remi s s ion in 3 5 % , s t able d i s e a s e  i n  
4 0 % , and re lapse i n  5 %  of the cases . O f  the 2 2  patient s who 
had met a s t a s e s  loc ated only wit hin the brain , 5 remained 
al ive for greater than two years . 
Low Grade As t rocytoma s 
Tre atment o f  pr ima ry l ow grade a s t rocytoma s wit h 
radiosurgery is not recommended becaus e  normal and mal i gnant 
g l i a l  cel l s  re s ide within t he target volume ( Larson et a l . ,  
1 9 9 3 ) . Larson et al e ( 1 9 9 3 ) devised a mode l to predict t he 
e f fects o f  a s ingle dose of radiation on the early responding 
tumor cel l s  and the late re s ponding normal tis s ue within the 
t a rget vol ume . They dete rmined t hat a d o s e  o f  3 0 - 4 0 Gy 
produced a radiobiologic e f fect of 5 0 - 1 0 0  Gy of f ract ionated 
r a d io t h e r apy on t he t umo r c e l l s  a n d  a 1 0 0 - 2 0 0  Gy 
radiobiologic e f fect on the normal t i s s ue within the target . 
Acc ording to Lars on ' s  mode l , radio s u r ge ry f o r  l ow gr ade 
astrocytomas will c ause a greater radiobiologic e f fect on t he 
norma l t i s s ue wit hin the target than on t he tumor c e l l s . 
The ir mode l sugge s t s  that normal tis sue in addition to tumor 
ce l l s  are kil led as a re s u l t  o f  radiosu rgery for l ow g rade 
astrocytomas . 
us ing LINAC radiosurgery , Poz z a  et al e ( 1 9 8 9 ) treated 1 4  
p a t ie n t s with i n o p e r a b l e  l ow g r a d e  ( WH O  I o r  I I ) 
a s trocytomas . Al l o f  the tumors were s pherical in s hape , no 
l arger than 3 0  mm in diameter , and had c lear-cut margin s . A 
dos age of between 1 6 - 5 0  Gy was given via mu ltiple noncopl anar 
arc s du r i n g  1 or 2 f r ac t ions s eparated by 8 d ay s . The 
pat ients were f o l l owed for a period of  1 1 - 4 8 months . Ten o f  
the 1 4  pat ient s s howed s ign i f ic ant improveme nt s  i n  t he i r  
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functional s t atu s . One pat ient who had a pre -radio s u r ge ry 
Karno f s ky s core o f  5 0 %  wa s scored at 1 0 0 %  at a f o l l ow u p  
t ime o f  4 8  mo n t h s . I n  t h r e e  pat i e nt s , t he r e  wa s n o  
improvement o r  only a s l ight improveme nt in their c l i n ic a l  
c onditions . One patient died 3 8  months a fter treatment . The 
two patients who rece ived two 2 5  Gy f ractions were the only 
s ub j ec t s  who d i s p l ayed s igns o f  acute toxic ity wh ic h were 
man i f e s t  a s  headache s . They we re treated with 4 mg o f  
dexamethas one 3 t ime s per day , and the s ymptoms s ub s ided 
after 7 to 21  days . Three pat ients s howed worsening of motor 
d i s turbances or  incre a s e s  in intrac r a n i a l  pre s s u r e  f rom 
mo n t h s  3 to 6 a f t e r  t r e atme n t . The s e  s ympt oms we r e  
attributed t o  a marked increase in the swe l l ing o f  the tumor 
o f  up to 9 5 %  a n d we re observed in 8 out o f  the 14  pat ient s . 
Swe l l i n g  occurred at a median t ime o f  4 . 5  mont h s  a f te r  
treatment . The swe l l ing s ubs ided from 1 2  t o  2 4  months after 
treatment . 
A l t h ou g h  P o z z a ' s  c l i n ic a l  t r i a l  f o r  l ow g r a d e  
a s t rocytoma u s ing L I NAC radio s u rgery demons trated impre s s ive 
re s u lt s , there have been no other pub l i s hed trials for t he 
r a d i o s u r g i c a l  tre atme nt o f  l ow grade a s t rocytoma s . Mo re 
c l inical trials s hould be conducted to determine the accuracy 
of the radiobiologic model developed by Larson et al . ( 1 9 9 3 ) . 
Gamma Kni f e  
The f irst s tereotact ic gamma unit was instal led in 1 9 6 8  
at the Karo l in s ka I n s t itute in S toc kholm . The u n it wa s 
created throu gh the combined e f forts and extens ive research 
o f  L ar s  Leks e l l , Bor j e  L a r s s on ,  a nd Kurt L iden . T h e i r  
prototype was des igned t o  produce s l it - l ike radiation les ions 
f or the purpo s e  of f u nc t ional radio s urgery . Neurol o g ic a l  
s ymptoms that we re t reated inc l uded : invo luntary movement 
d i s o r de r s , b e h a v io r a l  d i s o r de r s , a n d  t he r e l i e f  o f  
intractable pain . A second gamma knife was deve loped and in 
use at the Karo l i n s ka I n s t itute in 1 9 7 5 . I t  contained 1 7 9  
6 0 CO s ource s . This u nit wa s des igned to produce s pher ic a l  
l e s ions i n  order t o  treat arteriovenous ma l format ions ( AVM ) 
and brain tumors ( Leks e l l  1 9 8 3 ) . I n  the 1 9 8 0 s , the third and 
f ourth gamma unit s were instal led in Buenos Aires , Argentina 
and S he f f ield , Engl and re spectively . E ac h  of these contained 
2 0 1  6 0 CO s ources ( F igure 9 )  ( Wu et al . ,  1 9 9 0 ) . The f i ft h  
gamma kn ife was i n s t a l l e d  at the Univers ity o f  P itt s bu r g h  
Med ic a l  Center in 1 9 8 7  ( Luns ford et a l . ,  1 9 8 9 ) . The re a r e  
now approximately 4 2  gamma unit s  in operation worldwide . As 
of January 1 9 9 3 , over 9 , 0 0 0  pat ients have been tre ated wit h  
gamma k n i f e  wor l dwide . Approximately ha l f  were treated for 
vas c u l ar mal format ions , and the other hal f for brain tumor s . 
Funct ional radios urgery with gamma knife repre s e nted roughly 
four percent of the procedures ( Luns ford 1 9 9 2 ) . 
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Unl ike the L I NAC , whic h c an b e  u s ed f o r  conventional 
rad iotherapy to all body regions , the gamma knife i s  a u n it 
ded ic ated to radio s u rgery for t he brain . The gamma kni f e  
mus t  b e  hou s ed with in  i t s  own s u ite . At t he Univers ity o f  
P it t s burgh , the s u ite is l oc ated in t he b a s ement o f  t h e  
hospital and consists o f : a patient preparation area u s ed for 
t he app l ic at ion o f  the s t ereot a c t i c  g u i d i ng devic e , a 
treatment room , an image evaluat ion area , a control area , and 
a computer phys ic s  s ite ( Luns ford et al . ,  1 9 8 9 ) . 
The gamma knife cons ists o f  a permanent 1 8 , 0 0 0  kg c a s t  
iron s h ield which surrounds a central body cons i s t ing o f  2 0 1  
6 0 C O  s ources arranged in a hemi s phe r ic array . 6 0 CO has a 
hal f - l ife o f  5 . 3  years . At the t ime the s ources are loaded , 
e a c h  had an ave rage act ivity o f  3 0  C i  ( Lu n s f ord et a l . ,  
1 9 8 9 ) . E ach of the 2 0 1  60CO sources cons ists o f  2 0  pe l let s 1 
mm in diame ter that are s t ac ked atop one anot he r . T he 
pel lets are doubly encaps ulated in a stainles s steel caps u l e . 
The gamma kn i f e  a l s o  c o n s i s t s  o f  f ou r  inte r c h a n g e ab l e  
c o l l imator he lmets wit h diameters o f  4 mm ,  8 mm ,  1 4  mm ,  and 
1 8 mm .  Other components inc lude : a patient treatment table , a 
control console , a hydraul ic system, and a treatment-pl anning 
c omputer sys tem . Each o f  the 2 0 1  beams are directed through 
a beam c hannel whic h inc ludes a tungsten al loy prec o l l imator 
and a l e ad c o l l imator . Depe nding upon t h e  s i z e  o f  t he 
les ion , one o f  the four dif ferent sized col l imator he lmets i s  
u s ed i n  the f i nal c o l l imat ion . The c o l l imato r  he l me t s  
pos s e s s 2 0 1  channe l s  which are pe r f e c t l y  al igned wit h  the 
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c e ntral body . Al l o f  the 2 0 1  beams conve rge upon a s in g l e  
point a t  t he center o f  the radiation u n it ( Figure 1 0 ) . T he 
d i s t ance from the c o l l imator channe l  to t he s ingle point i s  
4 0 . 3  cm and i s  te rmed t h e  f o c a l  d i s tanc e . Any o f  t he 
col l imators may be plugged in order to prevent irradiation o f  
t h e  l e n s e s  o r  other c r it ic a l  s t ructure s  near t he t a rget . 
Within each helmet , there are a pair o f  trunions which s e rve 
to a f f ix the Leks e l l  stereotact ic frame . The central beam o f  
the 2 0 1  sources is a t  a f ixed angle o f  5 5 0 to the hor i z ontal 
p l ane . The sources are evenly distributed in an arc o f  ± 4 8 ° 
along the treatment table and ± 8 0 ° ac ro s s  the treatment table 
from the central beam ( Wu 1 9 9 2 ) . 
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Figure 9 :  G amma K nif e (Courtesy of E lek ta Radiosurg ery 
Atlanta ,  Georgia). 
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Figure 1 0 : C o l l imator Helmet and the converge nce o f  2 0 1  
beams upon the foc a l  po int (Courte sy of  Elekta Rad ios urgery 
At lanta , Georgia ) .  
Ganuna Kni f e  Radi o surge ry P r o c edur e  
Pat ients undergo the appl ic at ion o f  t h e  Leks e l l  Mode l G 
s tereotactic head f rame under local anesthe s ia . For children 
and t eenage patient s , frame p l acement and radios urgery are 
done u nde r gene ral ane s t he s ia ( Co f fey and Luns ford 1 9 9 0 ) . 
N e x t , t h e  i n t r a c r a n i a l  t a r g e t  i s  v i s u a l i z e d . F o r  
arter iovenous ma l format ions ( AVM ) , bipl ane ang iography i s  
u s ed . High resolution CT or MRI is used to visualize tumors . 
F rom these image s , the prec ise rec t i l inear ( x ,  y ,  a nd z )  
s t e re o t a c t i c  c o o r d i n at e s  o f  t he t a r g e t  are dete rmi n e d  
( Luns ford and Kondz iolka 1 9 9 2 ) . I n  order to account for the 
contours of the pat ient ' s  s kul l , a s pec ial plastic he lmet is 
u s e d . The helmet i s  attached to the ste reotactic frame and 
me asu rements are t ake n from t he center of the f rame to t he 
s u r f ace o f  the s ku l l  at 2 4  pre se lected point s . The gamma 
angle , wh ic h is def ined as the angle of the pat ient ' s  head 
with res pect to the s tereotac t ic f rame , is a l s o  determined 
( Wu 1 9 9 2 ) . Mu l t iple i s ocenters may be u s ed to irradiate 
l e s i o n s  t hat are too l arge to be c ir c ums c ribed by one 
i s ocenter , or whos e  irregu lar s hape nece s s it ates the use of 
more than one isocenter . Dose se lection is undertaken by t he 
neu ro s u rgeon and the rad iat ion onc o l o g i s t .  T hey s e l ec t  
do s age wit h res pect t o  prior therapy , l ocation and s i z e  o f  
t h e  t a r g e t , a n d  t u mo r p at h o l o gy . I n  g a mma k n i f e  
r a d io s u rgery , a n  1 8  mm c o l l imator i s  t he l a rge s t  o n e  
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available for use . Targets exist whos e  diameters are l arger 
t ha n  1 8  mm wh ich may ne c e s s itate the u s e  of mu l t ip l e  
isocenters ( Luns ford and Kondz iolka 1 9 9 2 ) . 
u s ing the e s t imated s t e re o t a c t ic c oo r d i n at e s ,  t he 
c o l l imator s ize , and the gamma angle , the treatment p l anning 
sys tem will calculate the isodose distribut ions for a l l  t hree 
axe s . A f t e r  t he c o o r d i n a t e s o f  t he t a r ge t  have b e e n  
de t e rmined , t he pat ie nt a nd t he s te reotact ic f r ame a r e  
a f f ixed t o t h e  t ru n io n s  o f  t he c o l l ima t o r  he l me t . A 
f l a s h l ight is directed through t he c o l l imators to determine 
t hrough whic h col l imator radiation might reach the lens e s  o f  
the eyes . Those co l l imators wil l  be plugged . The plugg ing 
patt e r n s  and the dose pre s c r iption are entered into t he 
treatment pl anning computer sys tem whic h calculates the t ime 
for each isocenter requ ired to del iver the prescribed dos e  to 
t he les ion ( Wu 1 9 9 2 ) . The gamma knife software system a l l ows 
for the viewing of a l l  of the 2 0 1  beams as they pas s through 
the c ranial vau lt and conve rge upon the foc al point ( Figure 
1 1 ) .  The goal of the treatment planning s e s s ion is to f u l ly 
e nc l o s e  the les ion margin within t he 5 0 %  i s odose l ine o r  
greater . This wi l l  e nab le t he maintenance o f  a s teep do s e  
f a l l - o f f  beyond the target margin . The t re atment p l anning 
may take f rom 2 0  minutes to s everal hou r s . The e n t i re 
rad ios u rgery proces s from the app l ic at ion to t he removal o f  
the stereotactic frame may take f rom 2 t o  5 hour s  ( Luns f ord 
and Kondz iolka 1 9 9 2 ) . 
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Figure 1 1 : G amma K nife System S oftwar e (Courtesy of E l ekta 
Radiosurgery Atlanta, Georgia). 
Initi a l  E xp e r i ence at the Univer s ity o f  
P ittsburgh 
The gamma knife fac il ity at the univers ity of Pitt s burgh 
t reated the f i r s t  pat ient in North Ame r i c a  on Augu s t  1 4 , 
1 9 8 7 . Over the next 1 6  months they treated 2 0 7  patient s ( 1 1 3  
had arter iove nou s ma l f ormations , 7 8  had ext r a - axial s ku l l  
bas e neoplasms , 9 had gl ial neoplasms , and 7 had metastat ic 
tumors ) .  I n  orde r to be cons idered for radio s u rge ry , the 
pat ient s had t o f u l f i l l  one or mo re of t he f o l l ow i n g  
c rite r ia : 1 )  t h e  pat ient had an AVM or int rac rania l tumo r  
that was cons idered unresectable ; 2 )  the pat ient was e l derly 
or had a s igni f icant medic a l  condit ion that pos ed exce s s ive 
s u r g ic a l  r i s k s ; 3 )  a l t hough the p a t i e nt had u n d e r g o n e  
surgic a l  o r  endovascular embo l i z ation tec hnique s ,  rec urrent 
or re s idual tumor or AVM remained ; 4 )  the pat ient re fused t he 
rec omme ndat ion o f  direct s u rgical removal and requ e s t e d  
r a d io s u rgery i n s t e a d . Du ring t h i s  init i a l  g amma k n i f e  
radios urgery expe r ience , there wa s n o  s urgic a l  mort a l ity . 
Approx imately hal f o f  the pat ients requ ired ant ieme t i c s  t o  
a l l eviate nau s e a  and / o r  vomit ing and m i l d  ana l ge s ic s  t o  
c o n t r o l  p o s toperat ive h e a d a c h e s . O n e  pat i e n t  w i t h  a 
s ubcort ic al AVM and a known seizure dis order , had 2 grand mal 
s e izures 8 hours after radios urgical treatment . The s e i z ures 
c e a s e d  a f t e r  t he r a pe u t i c  a n t ic o nvu l s a n t  l eve l s  we r e  
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establ ished ( Luns ford et al . ,  1 9 8 9 ) . 
Gl iob l a stoma Mul t i forme a nd Anap l a stic 
A stro cytoma 
From Au gu s t , 1 9 8 7  to Ju ly , 1 9 9 0 , the U n ive r s ity o f  
P it t s burgh Gamma Knife Center treated 4 0  patients , nine with 
a GBM ( mean Karno f s ky pe r formance s core = 7 7 ) and four with 
an AA . S ix o f  t he GBM le s ions had volume s  between 1 - 1 0  c c  
and 3 were greater than 1 0  cc . Three o f  the AA tumors had a 
volume of between 1 - 1 0  cc and the fourth was l arger than 1 0  
c c . Three of the pat ients wit h GBM and 3 o f  t he pat ie nt s 
with AA we re diagno s ed via b iopsy . The other patients h ad 
be e n  d i ag n o s e d  hav i n g  u nde rgo ne p r e v iou s c r a n io t omy . 
Rad i o s u rgery wa s per f ormed as a " boos t "  to f ract ionated 
external be am irradiation whic h had con s i s ted o f  a tot a l  of 
between 55  to 6 0  Gy adminis tered in 30  to 35  fract ions ( 1 . 7 2 -
1 . 8 3 Gy / f ract ion ) .  Al l o f  the tumors except one GBM were 
completely enclosed within the 5 0 %  or greater isodose l ine s . 
The mean dos e  to the tumor margins wa s 1 6 . 1  Gy and the mean 
central tumor dose was 2 9 . 7  Gy . Of  the 1 3  patients treated , 
f o l l ow-up imaging s tudies were available in 6 pat ient s  with 
GBM and 4 pat ient s wit h  AA . Three AA and 4 GBM h a d  
s t ab i l i z e d  or dec re a s e d  in s iz e  for a s  long a s  1 8  mon t h s  
a fter radio s u rgery . However , 2 GBM and 1 AA c ont inued to 
grow . Three pat ient s with GBM d ied between 3 and 3 9  weeks 
a f ter radiosu rgery . No patient wit h AA d ied d u r i n g  the 
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fol low-up o f  up t o  2 4  months , but radiographic and c l in ic a l  
evidence o f  tumor progre s s ion deve l oped in o n e  pat i e n t . 
" Boos t "  radiosurgery was u s ed in add it ion to f rac t ionated 
external beam radiotherapy to achieve local tumor control in 
7 5 %  of  th e AA an d 6 7 %  o f  the GBM within the image de f ined 
t re atment vo l ume . However s ome pat ients with GBM died o r  
u nde rwent c l inical progre s s ion due to t he i n f iltrat ion o f  
neoplastic cel ls ( Cof fey e t  al . ,  1 9 9 2 ) . 
From January 1 9 9 0  to Au gu st 1 9 9 2 , 1 8  patient s with 2 0  
ma l i g n a n c i e s ( g l io b l a s t oma mu l t i f o rme o r  a n a p l a s t ic 
a s t rocytoma ) we re t reated at t he Mayo C l inic . Al l o f  the 
tumors were diagnos ed via b iopsy or craniotomy and s urgic a l  
re s ec t ion . The patient s  had a mean Karno f s ky pe r formance 
s c o r e  of 8 3 % . A l l p a t i e n t s r e c e ived c o nve n t i o n a l  
f r ac t ionated radiot he rapy be fore o r  a f t e r  radios u r g i c a l  
t r e atment ( 1 0 days a f t e r tre atme nt for newly d i a g no s e d  
tumor s ) . Hal f o f  the tumors were located in lobar regions 
and the re st  were located in the bas al gangl ia , thalamu s , or 
brains tem . The dos e p re s c r ibed to t he t u mo r  mar g i n s  wa s 
determined by a protocol based upon tumor volume . O f  the 1 4  
tumors  that we re f o l l owed-up wit h pos toperat ive imag i n g , 
eight decrea s ed in s i z e . 
i n  s ome i n s t a nc e s  t h i s  
s ix tumors inc re a s ed i n  s iz e , and 
oc c u r re d  a f t e r  i n i t i a l  t umo r 
s hr inkage . S ix o f  t he pat ients remained neuro l o g ic a l ly 
stable , one patient ' s  condition wors ened , and seven pat ients ' 
neurological conditions deteriorated , and they died . Al l o f  
the patients ' deaths were attributed to growth o f  the tre ated 
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l e s i o n . The me a n  s u rvival t ime wa s 1 0  mon t h s  a f t e r  
radiosurgery ( Cof fey 1 9 9 3 ) . 
C e r eb r a l  Meta sta s e s  
Twenty- s ix pat ients with twenty- s ix cerebral meta s t at ic 
tumors were treated with the gamma knife at t he Karo l i n s ka 
I n s t itute from 1 9 7 5  to March of 1 9 8 8 . I n  mos t  o f  the c a s e s , 
t he gamma kn ife rad io s urgery wa s the only treatment . The 
med ian treatment volume was 4 . 4 cc , the med ian average dos e  
wa s 5 3  Gy and t he med ian minimum tumor dose wa s 3 1  Gy . I n  
a l l  but one o f  the tumors , there was " s triking " s hrinkage o f  
t he tumors b e g i n n i n g  2 - 4  mo nths a f t e r  tre atme nt . Two 
met a s t a s e s  f rom me l anoma s and three f rom adenoc arc i noma s 
dis appeared completely between two months and one year a fter 
treatment . Four o f  these f ive tumors had volumes of 1 c c  or 
le s s , the other had a pretreatment volume o f  5 cc . Nineteen 
tumors that ranged in vo lume from 2 - 1 3  cc decreased by 7 5 %  
ove r a 3 - 6  month follow-up period . The pat ient that d id not 
re s pond to treatment had a metastas is in the brain s tem f rom 
an ovarian c arc inoma . S he rec e ived only a dose o f  1 3  Gy as  
the minimum dose t o the tumor ( Kihlstrom 1 9 9 1 ) .  
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Ar t e r i ov e nou s Ma l f o rma t i on s  
A r t e r i ove n o u s ma l f o r mat i o n s  ( AVM ) a r e  f i s t u l o u s  
commu nications between cerebral arteries and ve ins . The lack 
o f  an inte rvening c apil l ary network re s u l t s  in an inc re a s e d  
rate o f  blood f l ow ( Okaz aki 1 9 8 9 ) . The core o f  the AVM i s  
t h e  n idu s wh ic h i s  re s po n s i b l e  f o r  t h e  a r t e r iove no u s 
s hu nt ing . The nidu s i s  interpo sed between feeding arteries 
and terminal ve ins . Arte r ies that feed t he AVM inc lude : 
branches o f  the anterior , middle , and pos ter ior c e r e b r a l  
arterie s , the i r  pe r f orating branc he s , a n d  t h e  c ho r oi d a l  
arterie s . The ma in venou s drainage is via a s ingle l arge 
ve in . The draining vein is usually s ituated at the center o f  
t he l e s ion , and t hey empty into one o f  the venou s s inu s e s  
( Yas argil 1 9 8 7 ) . The feeding arteries and the draining veins 
are u s ua l ly enl arged . The n idu s i s  composed o f  a tangled 
ma s s  o f  s tructural ly abnormal blood ve s s e l s . The inte rnal 
e l a s t ic l amina may be interrupted . Wit hin a ves s e l , t h e  
mu s c u l a r  media may vary greatly in t hic kne s s . Thinning o f  
the media may lead t o  the format ion o f  an aneurysm ( Ru s s e l l  
and Rubens tein 1 9 8 9 ) . The ve s s e l s  o f  the n idus have a l s o  
bee n c haracteriz ed a s  " arter ial i z e d "  ve ins c ons i s t in g  o f  a 
thickened int ima and mu s c u l aris but l acking e l a s t ic t i s s ue . 
Al s o , the ves s e l s  have been characterized as having e ither a 
" c losed " or a fene s trated endothe l ial l ayer ( Yas argil 1 9 8 7 ) . 
Typ ic a l ly , an AVM l ie s  wit h in t he s ubarac hnoid s pace and 
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extends through the gray matter i n  t he s hape o f  t he c o ne . 
The apex o f  the cone points towards t he ventric les ( Okaz aki 
1 9 8 9 ) . 
Rad ios urgery i s  per f ormed in order to c au s e  a t o t a l  
obl iteration of t he AVM secondary to t he oc c l u s ion o f  t h e  
n idus . The prec ise mec hanism o f  ob l iterat ion has not yet 
been found . pathological evidence has s hown that endothe l ial 
pro l iferat ion may be the mos t  important f ac tor in c au s ing 
occlus ion . Radiat ion has been s hown to c ause obl iterat ion in 
s ma l l  ve s s e l s  due t o e ndothe l i a l  c e l l s we l l in g . P os t ­
irradiation changes in ve s s e l s  can be characterized a s  having 
an early or late time course . Early changes , occurring wee ks 
a fter irradiat ion , have been s hown to inc lude e ndothe l i a l  
c e l l  s we l l in g , d e g e n e r a t i o n , a n d  nec r o s i s . S u b s e q u e n t  
thrombosis of the ves se l  wal l s  has a l s o  been observed . Wee ks 
to months a fter irradiation , late changes are mani fest by the 
p ro l i f e rat ion of e ndothe l i a l  c e l l s  and s u b e n d o t h e l i a l  
connec tive t i s s ue with subs equent narrowing and occ lus ion o f  
ves s e l s  ( Bunge e t  a l . ,  1 9 9 2 ) . Al s o , i t  has been noted that 
t h e  a rt e r i a l  ve s s e l s  o f  AVM i nc u r  ob l ite rat i o n  mo r e  
f re qu e nt ly than normal arte r i a l  va s c u l ature wi t h i n  t h e  
t reatme nt f ie l d . A n  AVM that h a s  n o t  u ndergone c omplete 
obl iterat ion ha s approximately a 2 - 3 %  per year probab il ity o f  
u nd e r g o i ng s pontaneous b l e e d i n g . T h e  t ime c ou r s e  f o r  
complete obl iteration o f  a n  AVM c a n  range f rom 8 months to 2 7  
months ( Levy et al . ,  1 9 9 2 ) . The rate o f  total obl iterat ion 
at two years after radios urgery was shown to be approximately 
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8 6 % . During t he t ime a f ter rad io s u r ge ry but be fore total 
obl iteration , t he pat ient is still at ris k for hemorrhage 
( Steiner 1 9 8 5 ) . 
Exper iment a l  D e s i g n  
Hypothes i s  
T h e  add it ion o f  Vas c u l ar E ndot he l ial Growt h F a c t o r  
( VEGF ) and Bas ic Fibrob l a s t  Growth Factor ( bFGF ) a fter t he 
irradiation of a mic ros urgical ly c reated arteriovenou s s hunt , 
in laboratory rat s , wil l  result in a faster t ime course for 
vas cular obliteration than irradiat ion alone . 
Background 
Vas c u l ar Endothe l ial Growth Factor ( VEGF ) is a hepar in 
b i n d i n g  4 5  KDa c at io n ic p r o t e i n  t h at i s  s pec i f ic a l l y 
mitogenic for vascular endothe l ial cel l s  in vitro . VEGF was 
ide nt i f ie d  in the c ondit ioned media o f  bovine p itu it ary 
f o l l ic u l ar ce l l s  ( Ferrara and H e n z e l  1 9 8 9 ) . VE GF has a 
s ignal sequence ; there fore the protein is secreted ( Leung et 
al . ,  1 9 8 9 ) . Conditioned media from a human gl ioblastoma cel l  
l i ne e n h a n c e d  t he pr o l i f e r a t i o n  o f  bovine c ap i l l a r y  
e ndothe l ia l  c e l l s  ( BCE ) in vitro . T h e  numb e r  o f  B C E  
recovered from cultures treated with the condit ioned media o f  
the gl ioblastoma c e l l  l ine was over three t ime s greater than 
those cultured in 1 0 %  cal f serum . The ma j or act ivity in t he 
condit ioned med ium was found to be VEGF ( Goto et al . ,  1 9 9 3 ) . 
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I n  rats , binding s ite s for VEGF have bee n demon s t rated i n  
sections o f  kidney , brain , pancreas , and heart . The binding 
s ite distribution re f lects the vas culariz at ion o f  the organ . 
The VEGF binding s ites have been a s s oc iated with the vascular 
e nd o t he l i a l  c e l l s  of f e ne s t r at e d  and n o n  f e n e s t r at e d  
capillaries and the endothe l ium o f  l arge ve s se l s . Binding o f  
VEGF has been a s s oc iated with qu ies c ent and pro l i ferating 
endothelial cell s . This may support the hypothes is that VEGF 
plays a role in the maintenance and induct ion of endothel ial 
c e l l s . Al s o , a high den s ity o f  binding s it e s  h a s  be e n  
demons trated i n  the endothe l ial l ining o f  the heart va lve s 
which are constant ly sub j ected to the s hear forc e s  o f  b lood 
f l ow u nder high pres sure . VEGF cou ld there fore play a role 
in the continual repair and maintenance o f  endothe l ial c e l l s  
( Jakeman et al . ,  1 9 9 2 ) . However ,  it is not known whether the 
VEGF expres sed in normal tissues is s tored intracel lularly or 
is s ecreted continuou sly ( Senger et al . ,  1 9 9 3 ) . 
Bas ic Fibroblast Growth Factor ( bFGF ) i s  an 1 8 - 2 5  kDa 
prote in whose in vitro vascular targets inc lude : endothel ia l  
c e l l s , smoot h mu s c l e  ce l l s , a n d  f ibrob l a s t s .  Th i s  growt h  
f actor i s  a potent mitogen for the endothel ial cells of s ma l l  
and large ves sel s . Like VEGF , bFGF has a s trong a f f inity for 
the glycos aminoglycan heparin . However , bFGF does not have a 
s ig n a l  s equence ; t here f ore , the prote in i s  not s e c re t e d  
( D ' Amore 1 9 9 2 ) . Due t o  its lack of a s ignal s equence , i t  has 
bee n hypothes ized that bFGF is re leased in re sponse to ce l l  
i n j ury . Damage t o  the vas c u l a r  e ndot he l ial c e l l s  c ou l d  
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prompt the releas e of bFGF ( D ' Amore 1 9 9 0 ) . 
VE GF and b FGF have been s hown t o  s y nerg i s t ic a l l y  
inc rease the rate o f  vas cular endothel ial c e l l  pro l i ferat ion 
in vitro ( Goto et a l  1 9 9 3 ) . E ndothe l ia l  c e l l  swe l l in g , 
nec ro s i s , and l y s is doe s not appe a r  u nt i l  wee k s  a f te r  
irradiation . This may imply that bFGF is not re leased f rom 
the endothe lial cel l  cytopl asm unt il weeks after irradiat ion . 
The addit ion of bFGF and VEGF at some point after irradiation 
may s horte n the t ime cou r s e  of va s c u lar occ l u s ion due t o  
int imal thickening . Dec reas ing the t ime course for vas c u l ar 
oc c l u s ion fol l owing ir rad iat ion c o u l d  dec re a s e  t h e  t ime 
neces s ary for the complete obl iterat ion o f  the AVM f o l l owing 
radiosurgery . 
Exper imental Des ign 
The t ime c o u r s e  of a mic ro s c o p ic a l ly d i s c e r n a b l e  
re s ponse of vascular endothel ial c e l l s  t o  irradiat ion s hou l d  
b e  determined . This woul d  al low f or a c haracter iz ation o f  
t ime dependent endothe l ial c e l l  change s such as : swe l l ing , 
necros is , lysis , and prol iferation . The add ition o f  growth 
f actors to vas c u l ar endothe l ial c e l l s  at a t ime whe n  t hey 
h ave demon s t rated p he notyp ic c h a n ge and / or e n d o t h e l ia l  
p ro l i f e r a t i o n  may c a u s e  a n  i n c re a s e  i n  p r o l i f e r at ive 
a c t iv i t y . Al s o ,  t h e  g r owt h f a c t o r s  may i n d u c e  t he 
prol iferation of quiescent endothe l ial ce l l s  lying with in the 
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irradiation field . 
I n  order to s imulate an AVM in vivo , a 1 - 1 . 5  mm diameter 
arteriovenou s s hunt is mic rosurgic a l ly created between the 
abdominal aort a and the ve na cava of 2 4  l aboratory rats as 
de s c r ibed by Al t s chuler  et al e ( 1 9 9 2 ) and Mic kle et a l e 
( 1 9 8 1 ) . A small radiopaque metal c l ip is left at the s ite o f  
the f is tula t o  enab le radios urgical targeting . The f i s t u l a  
is allowed t o  mature for several weeks . The rat s  are divided 
into s ix groups ( lA ,  1B , 2A , 2 B ,  3A, 3B , n= 4 ) .  Those rats in 
the A groups wil l not be irradiated . us ing an a n ima l 
modif ic at ion of the Leksell Model G s tereotactic frame and a 
4 mm coll imator , the rats in the B groups wi l l  be s ub j ected 
t o  a maxima l dos e 4 0  Gy ( Al t s hculer et al . ,  1 9 9 2 ) . After 
irradiation or s ham, the rats wil l  be s acrificed according to 
the fol lowing t ime schedu l e : 1A and 1 B  ( 3  weeks ) ,  2 A  and 2 B  
( 6  months ) ,  3A and 3 B  ( 1 8 months ) ( Table 3 ) . At one hour and 
nine hours before s acrif ice , the rats wil l  be in j ected with 
t rit iated thymidine as de s c ribed by L inder et al e ( 1 9 9 0 ) . 
The rats will be s acrificed with an overdose o f  pentobarbitol 
and pe r f u s ed with 4 %  paraforma ldahyde in phos phate bu f f e r  
( O . lM ,  pH 7 . 3 )  at phys iologic f low for 4 minute s a s  des c r ibed 
by L inde r et a l e ( 1 9 9 0 ) . Next , the abdominal aorta and 
i n f e r io r  ve n a  c av a  wi l l  
( Lupinetti et al . ,  1 9 9 3 ) . 
unde r go H a u t c h e n  P r e p a r a t i o n  
The s e  e n  f ace preparations wil l  
a l l ow t he determinat ion o f  t he perc entage o f  e ndothe l i a l  
cel l s  that are i n  the s -phase via autoradiographic techniques 
de s c r ibed by L inder et a l e ( 1 9 9 0 ) . Al s o , port ions of the 
7 5  
arte riovenous s hunt , t he abdominal aort a , and the i n f e rior 
ve na c ava wi l l  be embedded , s e c t ioned , and s ta ined wit h 
hematoxy l in and eos in . The ir his topathology wil l  be s tudied 
under b r ight f ie l d  mic ro s copy in order t o  determine the 
pre s e nce o f  endothe l ia l  cel l : swe l l ing , nec ros i s , lys i s  a nd 
t hrombus format ion . The sections o f  the arteriovenous s hunt 
wi l l  a l s o  be prepared for autoradiographic analys is . I f  a 
phenotypic c hange i s  d i s c overed at any o f  t he three t ime 
points , addit ional experime nts s hou ld be c onducted in order 
to pinpoint the t ime course of post-irradiation changes . 
After determining the t ime c ou r s e  o f  pos t - irradiat ion 
phe notypic changes and / o r  endothe l ial ce l l  pro l i ferat ion , a 
separate experiment wil l  be conducted to study the e f fect s o f  
growth f actors o n  pos t - irradiation e ndot he l ia l  ce l l s . A I -
1 . 5 mm d iameter a r t e r iove nou s s hunt i s  mic ro s u r g i c a l l y  
c re ated between the abdominal aorta and t he vena c ava o f  3 6  
l aboratory rats as described by Altschuler et al e ( 1 9 9 2 ) and 
Mickle et al e ( 1 9 8 1 ) . A smal l radiopaque metal c l ip i s  left 
at the s ite of  the f istula to enable radios urgic al targeting . 
The f istula is allowed to mature for several weeks . The rat s 
are divided into four groups ( 1  - 4 ,  n= 9 ) . Anima l s  in group 
1 wil l not be irradiated and wil l  be in f u s e d  with 4 ml o f  
s a l ine . Members o f  group 2 wil l  not be irradiated , and t hey 
wil l  be infused with 2 ml of VEGF and 2 ml of bFGF . Group 3 
rat s wi l l  rece ive 4 0  Gy via gamma kni f e  radio s u rgery , and 
they wil l be infused wit h 4 ml of s a l ine . Rats in group 4 
wil l  also be sub j ected to 4 0  Gy and infused with 2 ml o f  VEGF 
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and 2 ml of bFGF . The groups wil l  be further subdivided into 
A ,  B ,  and C groupings . This de s ignat ion corre s pond s t o  t he 
t ime o f  s ac r i f ice  a fter infus ion . Rat s that make up t he A ,  
B ,  or C group will be s acrificed at 3 weeks , 6 months , and 1 8  
months re spectively ( Table 4 ) . The infus ion o f  growth factor 
or s a l ine is started at the pos t - irradiat ion t ime when there 
was a high endothe l ia l  ce l l  tritiated thymidine index and 
microscopically observed phenotypic change . 
The concentration of  the growth f actors that are to be 
adminis tered are 1 9 . 2  mg of  VE GF diluted in 2 ml of s al i ne 
and 1 . 2  mg o f  bFGF diluted in 2 ml o f  s a l ine . The i n f u s ion 
is to t ake place over an 8 hour t ime pe riod via a c at heter 
p l aced in the abdominal aorta . I nitial ly , 0 . 5  ml o f  the VEGF 
and 0 . 5  ml of  the bFGF s olut ion or 1 ml of s al ine are to be 
adminis tered in a bolus ( L inder et al . ,  1 9 9 0 ) . The t ime 
period o f  in fus ion and the concentrat ion o f  the bFGF were 
derived from an experiment conducted by L inder et al e ( 1 9 9 0 ) . 
L inde r et al e ( 1 9 9 0 ) studied the e f f ec t s  o f  0 . 0 6 mg /ml o f  
human bFGF o n  the prol i fe ration rat c ommon c arot id artery 
e ndothe lial c e l l s  whic h had been s u b j ected to mec ha n ic a l  
denudat ion . There was no reason given for the choice o f  the 
bFGF concentrat ion . Twenty- f ive percent of  the growth f actor 
was given as an initial bolus and the res t  was infused over 8 
hours . E ndothel ial cel l s  that received the bFGF infus ion had 
a t r it iated t hymidine index of 3 8 %  ve r s u s  2 %  f o r  t h o s e  
endothe l ial cel l s  given sal ine . The propo s a l  t o  administer a 
bFGF c once ntrat ion o f  0 . 6  mg / ml i s  being made in hope s o f  
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inc reas ing the rep l ication index and there fore the quantity 
o f  endothel ial ce l l s  in the arteriovenous s hunt . Goto et a l e 
( 1 9 9 3 ) found that VE GF and b FGF act s yne rg i s t ic a l ly t o  
inc rease endothel ial ce l l  proliferation i n  vitro . They c ited 
a VE GF : bFGF c o n c e n t r a t i o n  rat io of 1 6 : 1 .  T h i s  r a t i o  
corres ponds t o  t he c onc e ntrat ion o f  growth f actors i n  the 
proposed experiment . 
After the groups have been s ac r i f iced , t he abdomin a l  
aorta , vena c ava , and the arteriovenou s s hunt wil l  embedded , 
s e c t ioned , and s t a ined with hematoxy l in and e o s in . The 
t i s sue sections wil l  be sub j ected to planimetry measurements 
o f  the areas of  wal l  l ayers and lumens u s ing a computer i z ed 
p l a n imetry sys tem a s  de s c r ibed by Gi l lette et al e ( 1 9 8 9 ) . 
Measurements of  the areas of  the : int ima , media , advent itia , 
and lumen wil l  be made . Any thrombi pre s ent can be mea sured 
and expres sed as a perce ntage o f  the lumen it is occupying . 
Al s o , the extent o f  thrombi covering the intimal surface c a n  
b e  me asured by dividing the length o f  the thrombu s covering 
t he int ima by the total le ngth o f  t he int ima ( Gi l lette e t  
al . ,  1 9 8 9 ) . Stat i s t ic a l  analys i s  wi l l  be u s ed in order to 
de termine t he s ignif icance of  any inc re a s e s  in ves s e l  wa l l  
thic kne s s  or decreases in luminal area . 
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Dose 
o Gy 
( Control ) 
4 0  Gy 
3 weeks 
lA ( n=4 ) 
IB ( n=4 ) 
Time Course o f  S acri fice ( Tabl e 3 )  
Time 
6 months 1 8  months 
2A ( n=4 ) 3A ( n=4 ) 
2B ( n= 4 ) 3B ( n=4 ) 
7 9  
Conditions 
o Gy & 
4 ml saline 
o Gy & 
2 ml VEGF+ 
2 ml bFGF 
4 0  Gy & 
4 ml saline 
4 0  Gy & 
2 ml VEGF+ 
2 ml bFGF 
Experimental Condi t i on s  and Schedul e  of Sacri fice ( Table 4 )  
Time 
3 weeks 6 months 1 8  months 
1A ( n=3 ) 1B ( n=3 ) 1C ( n=3 ) 
2A ( n=3 ) 2B ( n=3 ) 2C ( n=3 ) 
3A ( n=3 ) 3B ( n=3 ) 3C ( n=3 ) 
4A ( n=3 ) 4B ( n=3 ) 4C ( n=3 ) 
C o n c lusion 
Radiosurgery u s ing the Linear Accelerator or the Gamma 
Kn i f e  has proven to be an e f fective t reatment modal ity f or 
mal ignant brain tumors . I n  comparison to other tre atments , 
rad iosurgery can be per formed on an outpat ient bas is and is  
noninvas ive ( Tab le 5 ) . Due to the functional propertie s o f  
radios urgical devices , they are ideal f o r  pat ient s who are 
u nable to undergo s u rgical removal of the ir brain tumors . 
The s harp dose drop-o f f  beyond the tumor margin allows for 
high dos age tumor irradiat ion while s paring normal brain 
tis sue . Many procedures that involve radiosurgery u s e  it as  
a U boost "  therapy in con j unction with s u rgical resection and 
who l e  brain irradiat ion . U Boos t "  therapy enhanc e s  t he 
standard treatment procedure for malignant brain tumors . 
unfortunately , radiosurgery is not always able to halt 
t he progres s ion of ma l ignant brain tumors .  Patient s wit h 
metastatic brain tumors usually s uccumb to sys temic diseas e . 
Patients who have gl iomas general ly die due to the inabil ity 
of local tumor control . However ,  the use o f  radios urge ry c an 
contribute to increas ing a pat ient ' s  qual ity of  life . O f ten , 
t re a tme nt is f o l l owed by a dec re a s e  in c ort ic o s t e ro i d  
administrat ion and a n  improvement i n  a patient ' s  neurological 
s tatus . The future directions of  radiosurgery cou l d  inc lude 
the development and implementation of a randomized s tudies to 
8 0  
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dete rmine a do s e -vol ume protoc o l  f o r  g l ioma s and t h e  
dif ferent forms of  metastases . Al so , a n  investigat ion s hou ld 
be undertaken to determine whether the use of  high ( 5 0  Gy or 
more ) radiosurgical dose s  as the only t reatment for g l iomas 
and c erebral metastases wou ld prove to be a more e f fec t ive 
use than "boost " therapy . 
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Summary o f  T reatment Moda l i t i e s  for Ma l i gnant Bra i n  Tumors ( Table 5) 
Aspects 
Invasive 
Total 
Radiation 
Total Treatment 
Time 
Tumor 
Dimensions 
Whole Brain 
No 
3 0 - 6 0Gy 
2-5  weeks 
N/A 
Modality 
Brachytherapy 
Yes 
5 0 - 1 5 0Gy 
7 2  hrs -
permanent 
les s than 6cm 
in greatest 
dimens ion 
Gamma Knife LINAC 
No No 
1 6 . 1 - 7 1Gy 9-5 0Gy 
2 - 5  hrs 2 - 3 hrs 
O . 3 - 1 3cc O . 5-2 7cc 
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